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ABSTRACT 
 
 Impaired wound healing induced by obesity is a major health care concern.  Non-healing 
wounds account  for greater than $25 billion in annual health care costs in the United States alone.  
Thus, therapies to speed healing are of major interest, and research into a number of therapeutic 
wound treatments is currently ongoing.  Previous research indicates that short-term treadmill 
exercise training can speed wound healing rate in aged mice.   As aged mice have impairments in 
wound healing similar to those seen in obese mice, we hypothesized that a similar exercise 
paradigm might speed healing rate in a high-fat diet-fed mouse model of obesity.  We also examined 
whether exercise training would reduce wound inflammation in these mice, as exaggerated 
inflammatory responses are known to impair healing in obesity and as exercise training has been 
shown to reduce inflammation in a variety of tissues, including in wounds of aged mice. 
 Therefore, we exercised mice for 3 days prior-to and 5 days post-exercise and measured 
wound area to day 10 post-wounding.  Additionally, we measured non-wounded skin and wound 
site inflammation and growth factor expression through gene and protein expression analyses at 
baseline and at days 1, 3, and 5 post-wounding.  Further parameters measured included exercise 
effects on adipose tissue inflammatory cytokine gene expression, on skin and wound macrophage 
number and phenotype, and on blood glucose kinetics. 
 Exercise sped healing rate in obese mice, with the major effects happening early (within 5 
days) post-wounding.  Surprisingly, wound site inflammation was not affected by exercise, with no 
differences detected in gene or protein expression of inflammatory mediators or growth factors in 
non-wounded skin or in wounds at any time point after wounding.  There was a moderate non-
significant effect of exercise in reducing macrophage number in non-wounded skin, and there were 
no differences in fasting or stimulated blood glucose responses between exercised and sedentary 
obese mice.  Interestingly, adipose tissue gene expression of several inflammatory cytokines were 
increased 2-3 fold in exercised mice, significantly so in several cases in the epididymal adipose 
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depot.  Additionally, epididymal adipose tissue expression of macrophage marker F4/80 was non-
significantly increased, while in subcutaneous adipose tissue the expression of this marker was 
slightly decreased. 
 Thus, while exercise was shown to speed healing in obese mice, the mechanism by which it 
acts is still unclear.  Future research focusing on macrophage number and function in non-wounded 
skin of obese mice is necessary, as is research examining other potential mechanisms including 
exercise-enhanced wound contraction and exercise-induced alterations in skin microbiota.  Finally, 
translational research is necessary to apply the findings here to a human population as it is not 
currently known whether exercise can speed healing in obese individuals in a clinical setting.  
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CHAPTER 1 
 
INTRODUCTION 
 
 
1.1  Significance 
 Obesity has become a major health concern in the United States (US) in the last 50 years.  
From 13.4% prevalence in 1962, the percentage of US adults considered obese reached 30.9% in 
the year 2000 (8).  This trend has continued, as the most recent national data indicates that nearly 
34% of Americans can be considered obese, with more than 30% of the remainder now classified as 
overweight (7).  Obesity and obesity-related disorders account for more than 300,000 deaths per 
year in the US alone (2) and were responsible for $78.5 billion in healthcare costs as far back as 
1998 (6), a number that has surely increased concomitant with the increase in obesity seen in the 
last decade. 
 Obesity and obesity-associated disorders such as cardiovascular disease (19), infectious 
disease (15), metabolic syndrome/diabetes (20), cancer (14, 21), and chronic kidney disease (12) 
are known to involve a dysregulation of the immune response including upregulated basal 
inflammation (9, 10) at both systemic and local adipose tissue levels.  This aberrant inflammatory 
response is also associated with impairments in wound healing in obese individuals (26).  This 
includes delays in healing of acute wounds and failure to heal chronic wounds; the latter of which 
leaves the individual prone to infection and other complications. Diabetes is a leading cause of 
amputations in the US annually (1). 
 A number of studies have shown that delayed healing in animal models of obesity is 
associated with dysregulated inflammation.  In genetically-obese mice, delayed healing has been 
shown to be associated with increased wound levels of pro-inflammatory chemokines (25) and 
cytokines (11).  Moreover, depletion of inflammatory cells including neutrophils (3) and 
macrophages (11) as well as treatment with neutralizing antibodies against pro-inflammatory 
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cytokines such as tumor necrosis factor-α (11) have been shown to speed healing in genetically-
obese animal models.  This may be mediated by prolonged induction of inflammation through 
macrophage dysfunction, as wound-associated macrophages in obese animals have been shown to 
fail to perform essential functions such as clearance of apoptotic neutrophils (17); a process that is 
necessary to switch the macrophage from a pro-inflammatory phenotype to an anti-inflammatory, 
pro-healing phenotype.  Thus, interventions that target increased wound-associated inflammation 
and speed healing in obese individuals are of major public health and research interest. 
 Exercise is well known to decrease inflammation in obese individuals at both systemic (5, 
22) and adipose tissue-specific (24) levels.  However, no studies to date have examined the effects 
of exercise training on healing rate or wound inflammation using an obesity model of delayed 
healing.  Interestingly, exercise has been shown to speed healing in aged mice (16) and older 
humans (4) and reduce inflammation in the wounded tissue of aged mice (16).  As aging causes 
increases basal levels of inflammation similar to that seen in obese individuals (18), similar 
mechanisms might allow exercise to speed healing in obese and diabetic individuals.   
 Therefore, the goal of this study is to determine the effects of exercise on the wound healing 
process in obese mice.  A diet-induced obesity (DIO) model in which obesity is induced by feeding 
of a high-fat diet (45% kcal from fat) was chosen as evidence suggests that DIO models are most 
appropriate for studies of acute wounds while genetically-obese models are most appropriate for 
chronic, non-healing wound models (23).  The intent of the exercise model used in this study as 
well as in the Keylock et al. study in aged mice (16) is to determine if a short-duration exercise 
training program performed within a known time frame prior to and after wounding can speed 
healing and lessen wound inflammation.  This intervention is targeted as a type of “prehabilitation” 
for obese individuals who are scheduled to undergo procedures such as bariatric surgery that will 
create cutaneous wounds.  As wounds from such procedures are known to heal slower in obese 
3 
 
individuals (26), results from this study may be useful clinically to prescribe treatment regimens to 
lessen healing time and reduce wound complications in obese surgical patients.  
 
1.2  Specific Aims 
 This study, the first to examine the role of exercise training on skin wound healing in 
obesity, has four specific aims.  These are presented below.  Methods, hypotheses, expected results, 
and alternative hypotheses are presented briefly.  A full description of the study methodology, 
including experimental design and statistical analysis, can be found in Chapter 3. 
1.2.1  Specific Aim #1 
  Assess the effects of exercise training on wound healing kinetics in DIO mice.  The 
exercise paradigm includes both a pre-wound (3 days) and post-wound (5 days) component.  This 
paradigm matches that used in Keylock et al. (16), which found the exercise sped healing and 
decreased wound inflammation in aged mice.  Two full-thickness wounds are placed on the shaved 
dorsum of the mouse using a 6mm punch biopsy instrument.  Wounds are then photographed daily 
for 10 days post-wounding and assessed for healing using photoplanimetry.  Wounds are also 
followed to full closure. 
 It is hypothesized that exercise will speed healing in DIO mice and result in decreased time 
to total closure.  Keylock et al. (16), who found similar results in aged mice, demonstrated that most 
effects of exercise were early post-wounding (days 1-5) with the greatest effect at day 1 post-
wounding.  If this holds true in obese mice, as hypothesized, it will suggest that exercise affects 
mainly the early stages of wound healing, specifically the inflammatory phase.   
 Alternately, should exercise not have a detectable effect on healing, it may suggest that the 
exercise paradigm is not sufficient to induce the necessary changes in inflammation which may be 
required to speed healing in an obesity model.  Vieira et al. (24) found that 12 weeks of exercise 
training was sufficient to induce decreases in adipose tissue inflammation, whereas 6 weeks of 
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training did not affect most measured parameters.  Therefore, should the proposed 9 day exercise 
intervention used by Keylock et al. (16) be insufficient to increase healing rate, a longer duration 
exercise training regimen (e.g. 8 or 12 weeks) could be used.  
1.2.2  Specific Aim #2: 
 Assess the effects of exercise training on wound inflammation in DIO mice.  Using an 
identical exercise paradigm to that described in Specific Aim #1, mice will be assessed for wound 
inflammation by measurement of gene and protein expression of selected inflammatory markers.  
Wounds will be harvested from mice at days 1, 3, and 5 post-wounding for analysis.  Total RNA and 
protein isolated from the wounds will be used for reverse transcriptase polymerase chain reaction 
(RT-PCR) and enzyme-linked immunosorbant assay (ELISA) analysis of cytokines, chemokines, and 
growth factors associated with inflammation and cell mobilization, proliferation, and migration in 
the wound tissue.   
 It is hypothesized that exercise will reduce inflammation in the wounded skin tissue of DIO 
mice similar to that seen in aged mice in Keylock et al. (16).  Additionally, an induction in the 
expression of anti-inflammatory mediators and pro-angiogenic and pro-healing growth factors is 
expected.  As obesity and aging result in exaggerated inflammation in cutaneous wounds and 
slower healing (13), these results would suggest that an exercise-induced reduction in 
inflammation is responsible for the increased healing rate hypothesized in Specific Aim #1. 
 Alternately, exercise training may play no role in the inflammatory process, or may even 
induce greater inflammation than in sedentary mice.  Should either of these occur, it would suggest 
that exercise modulates healing rate by a mechanism other than reduction of the increased wound 
tissue inflammation seen in obesity.  In this case, exercise-induced changes in tissue hypoxia are 
hypothesized to play a more important role in the changes in healing hypothesized to occur with 
exercise in obese mice.  Upregulation of vascular endothelial growth factor (VEGF) and of markers 
of wound hypoxia including hypoxia-inducible factors (HIF) would suggest an increase in 
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angiogenic potential in the wound area and will be measured by RT-PCR analysis of gene 
expression of these markers.  
1.2.3  Specific Aim #3 
 Assess the effects of exercise training on wound cellular infiltration in DIO mice.  
During normal wound healing, a number of cell types are induced to proliferate and to migrate to 
the wound tissue to effect healing (13).  For this aim, the exercise protocol will be identical to those 
of Specific Aims #1 and #2.  Cutaneous wounds will be collected for analysis of cell infiltration via 
immunofluorescence histology.  Results from Specific Aim #2 will inform the choice of collection 
day.  Should inflammation prove to be altered in the wounds of exercised mice, wounds will be 
collected at early time points such as day 1 or 3 post-wounding for analysis of macrophage number 
and phenotype.  If the alternative hypothesis is correct and proliferative and remodeling events 
prove to be altered in the wounds of exercised mice, wounds will be collected for analysis at later 
time points such as day 6 or 8 post-wounding. 
 It is hypothesized that inflammatory cell number and function in the wound tissue will be 
altered by exercise in obese mice.  Specifically, inflammatory cell number is expected to decrease 
slightly, while leukocyte function is expected to increase.   
 Alternately, should exercise be found to play no role in inflammatory cell number or 
function, similar measures can be performed on keratinocytes and endothelial cells to determine if 
tissue remodeling plays a more important role in healing in these mice.  An increase in the numbers 
of these cells with exercise would indicate, respectively, an increase in re-epithelialization and 
angiogenesis in the wound area.  Histological and IHC analysis of wound sections would be 
performed to confirm the presence of new epithelium and increased numbers of blood vessels at 
the wound site. 
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1.2.4  Specific Aim #4 
 Assess the effects of exercise training on wound healing in non-obese mice.  Finally, 
Specific Aims #1 and #2 will be repeated using young, non-obese mice.  Keylock et al. (16) showed 
that, although non-significant, exercise tended to speed healing in young healthy mice.  However, 
this was to a lesser extent than was seen in aged mice.  If, as hypothesized, exercise speeds wound 
healing rate in young mice in this experiment, and if the microenvironment of the wound proves to 
be altered similarly in exercised young mice as it is in exercised obese mice compared to their 
respective controls, future studies can utilize young mice for mechanistic work and can avoid the 
time and expense necessary to house and feed mice prior to the intervention.   
 
1.3  Summary 
 
 The overall aim of this study is to determine the effects of a short-term exercise training 
program on wound healing in DIO mice.  Specifically, these experiments will address whether 
exercise speeds healing in these mice, and whether the alteration of healing in exercised mice is 
associated with a decrease in wound inflammation and an enhancement of leukocyte function in the 
wound tissue.  Alternatively, exercise may not alter inflammation but may instead enhance 
parameters of wound remodeling, including fibroblast and endothelial cell function and 
angiogenesis.  Finally, the effects of exercise on wound healing in young mice will be tested as this 
wound healing model, should it be successful, would represent a cheaper and less time-consuming 
method of assessing the exercise effect on wound healing in future studies. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1  Wound Healing  
 Normal wound healing can be broken down into a number of phases.  Despite 
disagreements in the literature about the precise number of phases, wound healing can be thought 
of as consisting of four sequential and overlapping components.  These are, in temporal order, 
hemostasis, inflammation, proliferation, and tissue remodeling/resolution (39, 47, 112).  
Alterations in one or more of 
these phases can result in delayed 
healing and increased pain and 
risk of infection as well as 
decreased quality of life for the 
wounded individual.  In certain 
circumstances, chronic wounds 
develop in which the wound site 
does not heal or heals very slowly 
(>8 weeks).  This is common in 
type 2 diabetics (10) and is a 
major contributor to the majority of amputations performed in the United States each year (1).  The 
molecular events in each of these phases are outlined below, and temporal regulation of normal 
healing is shown in Figure 2.1. 
2.1.1  Hemostasis 
The initial phase of wound healing involves a rapid hemostasis which commences immediately 
after wounding (47).  Vascular constriction and fibrin clot formation cuts of blood supply to the 
Figure 2.1.  Phases of wound healing.  A) Kinetics of cellular migration 
during normal wound healing.  B) Time course of phases of wound 
healing.  MΦ, macrophage.  Adapted from Gosain & DiPietro, 2004; 
Goldberg & Diegelmann, 2010; Witte & Barbul, 1997.  
A 
B 
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wound in order to prevent blood loss from hemorrhage.  Growth factors and cytokines are then 
released from tissue in the wound microenvironment.  These factors induce the migration of 
leukocytes into the wound tissue, which results in a pro-inflammatory state (47).   
2.1.2  Inflammation 
 The earliest invading leukocytes are neutrophils (polymorphonuclear cells, PMNs), which 
are responsible for removal of cellular debris from the wounding process and for clearance of 
microbial pathogens from the wound microenvironment through phagocytosis, thereby lessening 
the risk of infection.  Within a period of 1-2 days following wounding, activated neutrophils 
undergo apoptosis, allowing for their removal by macrophages (60).  This process both minimizes 
the bystander damage that can be caused by activated neutrophils as well as lessens the risk of the 
spread of infections which may occur as a result of pathogens (mainly bacterial) which can infect 
and propagate in phagocytic immune cells (69). 
 In addition to neutrophils, macrophages play an important role in the wound healing 
process.  Resident macrophages in the tissue surrounding the wound site play an early role in the 
release of cytokines and growth factors which can attract other wound cells (including PMNs and 
monocytes) to the wound tissue (47).  At 2-3 days post-wounding, invading monocytes differentiate 
into macrophages and allow for additional inflammatory processes to occur (80).  Macrophages, 
similar to PMNs, participate in the removal of microbial pathogens and the generation of anti-
microbial reactive oxygen species (ROS) such as nitric oxide and peroxide (112).  Macrophage-
assisted wound debridement occurs via the production of collagenase, elastase, and other enzymes 
which digest damaged tissue to allow for wound remodeling to take place (112).  Production of 
cytokines and growth factors by macrophages are important regulators of chemotaxis of fibroblasts 
and endothelial cells (5), both of which are important for the proliferative and remodeling phases of 
healing.  Thus, macrophages play an integral role in promoting remodeling functions such as 
angiogenesis and extracellular matrix (ECM) synthesis beyond their pro-inflammatory roles in the 
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healing process.  Indeed, treatment of rats with a monoclonal antibody against macrophages 
reduces wound-breaking strength and collagen deposition in wounds (80). 
 Additionally, apoptotic neutrophils are phagocytized by macrophages in a process known as 
efferocytosis.  Efferocytosis allows, by a mechanism that has not yet been well-defined, for a 
phenotypic switch in macrophages to an anti-inflammatory state (27).  This switch helps to reduce 
inflammation in the wound tissue and thereby  pave the way for transition to the later phases of 
healing.  Thus, the phagocytosis of neutrophils by macrophages causes the resolution of the 
inflammatory phase of healing and allows the proliferative and tissue remodeling phases of healing 
to proceed. 
 T-lymphocytes (T cells) play an important role in healing, especially late in the 
inflammatory phase and early in the proliferative phase, with a peak at day 7 post-wounding (32).  
Although much research remains to be done in this area, preliminary evidence indicates a slight 
positive role for CD4+ T-helper (TH) cells in wound healing, particularly in increasing wound 
breaking strength (19), while increases in CD8+ cytotoxic T cells (TC) tend to delay healing rate (6, 
80).  Several specialized subsets of T cells also play a major, albeit incompletely understood, role in 
healing.  Skin-associated gamma-delta (γδ) T cells act as early responders in the inflammation 
process and assist in the healing process through the maintenance of tissue integrity as well as 
through more conventional immune roles such as the clearance of pathogens and the production of 
cytokines (47).  These resident γδ T cells also interface with keratinocytes and cause an increase in 
proliferation of these cells (52), a process which speeds healing.  Recently, natural killer T (NKT) 
cells have been shown to be involved in very early stages of wound healing and to delay healing 
through increases in inflammation and reductions in collagen deposition (91, 92), although the 
precise functions of these cells in the wound state are not currently clear.   
 Finally, cytokines and growth factors released from both immune and non-immune cells in 
the wound and surrounding tissues play a major role in the process of healing, although their 
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precise roles are sometimes debated.  Cytokines such as interleukin (IL)-1, IL-6, and tumor necrosis 
factor (TNF)-α as well as growth factors such as transforming growth factor (TGF)-α, TGF-β, 
platelet-derived growth factor (PDGF), and insulin-like growth factor (IGF)-1 can stimulate 
angiogenesis and collagen synthesis in the wound microenvironment (80).  Most of these factors, 
with the exception of the interleukins, also stimulate endothelial cell and fibroblast proliferation 
(80).  Some studies have shown differential effects of these molecules on healing, suggesting that 
further mechanistic and time course work might be necessary to fully describe the roles of these 
proteins in the healing process.  Demonstrating this, knockout of TNF-α promotes excessive 
granulation tissue formation and impairs re-epithelialization in cutaneous wounds (95), while 
ablation of IL-1 signaling through knockout of the IL-1 receptor reduced fibrosis and improved 
tissue remodeling using a similar model (104).  Further, loss of granulocyte/macrophage colony-
stimulating factor (GM-CSF) impaired healing and reduced cytokine production (including MCP-1 
and IL-6) at the wound site (28).  Thus, pro-inflammatory cytokine signaling is necessary in most 
cases for proper wound healing, although aberrant inflammation can delay healing in certain 
disorders, including obesity.  This will be discussed in detail below. 
2.1.3  Proliferation and Tissue Remodeling 
 Following the inflammatory phase of healing at about day 4-5 post-wounding, robust 
proliferation of reparative cells occurs.  Epithelial cells (keratinocytes) migrate to the wound site 
and proliferate in a process known as re-epithelialization (75).  A fibrin-rich provisional matrix 
allows for integrin-dependent keratinocyte migration and attachment in the wound.  Basement 
membrane (types IV and VII) and interstitial (types I, III, and VI) collagens help anchor 
keratinocytes at the provisional matrix.  During migration, keratinocytes secrete collagenases 
including matrix metalloproteinase (MMP)-9, a process which is necessary to remove damaged 
tissue and provisional matrix and to allow for uninhibited migration in the wound site. 
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 Fibroblasts and endothelial cells in the dermal layer allow for collagen deposition and 
angiogenesis as well as for granulation tissue formation at the wound site (47).  Endothelial cells 
(ECs) migrate and proliferate to form new blood vessels to allow for increased flow of oxygen and 
cells to the wound tissue (8).  This process is stimulated by the release of pro-angiogenic growth 
factors including TGF-β, PDGF, and vascular endothelial growth factor (VEGF), which induce 
proliferation and migration of ECs to the extracellular matrix where new vessels are formed.  
Similar to keratinocytes, ECs release proteolytic factors including collagenases to disrupt the ECM, 
allowing for migration into the wound area (13).   
 Fibroblasts, induced by hypoxia in the wound tissue, migrate and release collagen, 
fibronectin, and other components of the ECM (18).  These ECM constituents form the granulation 
tissue that allows for keratinocyte and EC migration and provides strength and integrity to the 
wound.  Apoptosis of fibroblasts occurs later in healing during the transition from the proliferation 
to remodeling phases and allows for final healing or scar formation to occur.  Contraction of the 
wound site occurs throughout this phase, a process which is thought to be induced by migration 
and activation of specialized fibroblasts, known as myofibroblasts, in the wound tissue (18, 47).  In 
the final remodeling phase of wound healing, new capillaries regress and ECM is remodeled such 
that the architecture of the wound site closely mimics that of normal tissue.  Full remodeling of the 
wound tissue to return it to a normal state is a process that can last for years (47).  
 Importantly, the mechanisms of normal healing differ between humans and mice.  Skin 
architecture in mice is distinct from that of humans.  In addition to the presence of hair covering 
much of the body, mice lack sweat glands and dermal papillae, both of which are present in humans 
(113).  Additionally, mice heal primarily through contraction of the wound site, while humans heal 
via granulation tissue formation and re-epithelialization as described above (36).  Thus, it is critical 
to understand the differences in healing mechanisms between organisms, as discoveries made 
using one species may not fully translate to wound healing strategies of another species. 
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2.1.4  Alterations in Wound Healing 
 A number of factors can cause dysregulation of the wound healing process and can 
significantly slow or even halt healing.  At the systemic level, age, gender, hormone status, obesity, 
stress, medication use, alcoholism, smoking, poor diet, and immunocompromising conditions can 
delay or alter healing rate (47).  Altered inflammation is associated with delayed healing in aged 
populations (101), and these alterations can result in reductions in angiogenesis and remodeling of 
the wound site in these populations.  Interestingly, although inflammation in these individuals 
seems to be increased, macrophage function seems to be reduced (45), suggesting that risk of 
infection may be increased in aged individuals despite their abnormally-high levels of local tissue 
inflammation. 
 Use of anti-inflammatory medications such as glucocorticoids, non-steroidal anti-
inflammatory drugs (NSAIDs), and chemotherapeutics have been shown to slow healing, mostly as 
a result of interference with platelet function or inflammatory processes (47).   In addition, stress 
responses are well known to be detrimental to the wound healing response.  Psychological stress, 
through the induction of glucocorticoid (GC) expression, reduces expression of inflammatory 
mediators and chemokines in the wound tissue (38) and can inhibit the influx of inflammatory cells 
such as PMNs and macrophages into the wound environment (38, 99), thereby disrupting the 
repair process.  However, acute stress can increase immune responses and may be potentially 
protective against delayed healing (22), a finding which may parallel those seen in the exercise 
literature.   
 Finally, a major area of interest in the area of wound healing is that of the effects of obesity 
and diabetes on the healing process.  In addition to the myriad of disease conditions to which 
obesity is related, obese persons are at greatly increased risk of wound complications including 
infections, pressure and venous ulcers, and delayed healing after major surgeries (47, 111).  Thus, 
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interventions which can combat these phenomena are of great interest to the medical community 
and are the focus of a number of current studies, including those described herein.  
 
2.2  Obesity 
 The prevalence of obesity in the United States (US) has risen drastically in the past half-
century, from 13.4% among US adults in 1962 to 30.9% in 2000 (34).  This trend has continued in 
recent years, as the most recent data from the National Health and Nutrition Examination Survey 
(NHANES) indicates that 33.8% of US adults can be considered obese (Body Mass Index, BMI > 
30.0) (33).  Early in the new millennium, the US Surgeon General’s Healthy People 2010 initiative 
established a national program for the reduction of obesity, setting goals for individual states at 
15% incidence of obesity in the adult population.  As of 2010, no state has reached this goal (2).   
 The consequences of obesity are numerous.  Nearly 300,000 deaths/year are attributable 
directly or indirectly to obesity (3), a figure that represents approximately 10% of the total all-
cause mortality in the United States annually.  Overweight- and obesity-related healthcare expenses 
accounted for approximately $78.5 billion in 1998, 9.1% of total US healthcare expenditures for 
that year (31).  Additionally, obesity is associated with a number of complications, including 
increased risk of cardiovascular disease (67), greater propensity for infection (56), development of 
metabolic syndrome and diabetes (70), and increased risks of cancer (48, 82) and chronic kidney 
disease (46).  Many of these co-morbidities are associated with aberrant inflammatory responses 
and decreased function of immune cells, suggesting a dysregulation of the immune system in the 
obese state. 
2.2.1  Inflammation 
 White adipose tissue (WAT), a major site of energy storage in humans and other mammals, 
contains not only adipocytes but also a number of associated cell types including notably 
macrophages and other leukocytes.  Underlying the many diseases and conditions associated with 
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obesity is a chronic state of low-level inflammation higher than that found in non-obese healthy 
individuals (29).  In the WAT of obese individuals, adipocytes and associated stromal vascular cells 
(SVC), including macrophages, release inflammatory mediators including cytokines such as TNF-α 
and IL-1β as well as chemokines such as monocyte chemoattractant protein (MCP)-1 (37).  Obesity 
is associated with an increased content of macrophages in adipose tissue (109), suggesting a 
possible mechanism by which inflammation may be triggered in the obese state.  Additionally, 
larger adipocytes are also correlated with increasing expression of pro-inflammatory adipokines 
(97). 
 Currently, it is hypothesized that the increase in local adipose tissue inflammation in 
obesity results in the chronic systemic low-grade inflammatory state seen in obese individuals, a 
phenomenon which is associated with the development of a number of comorbidities, perhaps the 
most important of which is cardiovascular disease (37).  Systemic inflammatory indicators such as 
C-reactive protein (CRP) and IL-6 are upregulated in the obese state, as are local inflammatory 
mediators such as TNF-α (7, 105).  Importantly, local inflammation is detectable in peripheral 
organs adjacent to as well as distant from the major adipose depots, suggesting that local adipose 
tissue inflammation may be playing a role in the spread of inflammation systemically (7).  The 
majority of these mediators, as well as chemokines such as MCP-1 and IL-8, are released by non-
adipocyte SVCs such as macrophages (105), thus these adipose-associated cells are of major 
interest in this area of research. 
 Obesity-related cytokines mediate their inflammatory effects by signaling through the 
nuclear factor kappa-B (NFκB) and c-Jun N-terminal kinase (JNK) pathways (37), with NFκB 
signaling stimulated through activation of IκB kinase (IKK)-β (4).  Inflammatory signaling through 
IKK-β and NFκB as well as TNFα-induced JNK stimulation of insulin receptor substrate (IRS)-1 
activity lead to insulin resistance and the eventual development of diabetes in obese individuals 
(37).  Additionally, recent evidence implicates saturated free fatty acids, which are released in large 
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quantities from adipocytes in obese individuals, in the stimulation of toll-like receptor (TLR)-4 , a 
pattern recognition receptor (PRR) classically responsible for stimulation of inflammatory 
responses through NFκB signaling after exposure to bacterial lipopolysaccharide (LPS) (100). 
 The mechanisms which underlie the increased inflammation in WAT of obese individuals 
have received considerable attention over the past few years.  The link between adiposity and 
inflammation is outlined in Figure 2.2.  Increased adiposity results in enlarged adipocytes, which 
eventually outgrow their blood supply.  Hypoxia-induced dysfunction of adipocytes has been 
observed in both animal models (51) and humans (81).  This is thought to induce necrosis of 
adipocytes, and necrotic adipocytes have been shown to be present in fat pads of high-fat diet-fed 
mice but not lean mice (17).  This is associated with the development of crown-like structures, a 
phenomenon in which macrophages migrate to the site of tissue necrosis and surround the dying 
cell, presumably in an effort to clear debris associated with tissue death (17).  Necrotic tissue 
releases damage-associated molecular patterns (DAMPs), endogenous molecules such as fatty 
acids, heat shock proteins (HSPs), and genomic DNA which act as ligands for macrophage PRRs  and 
activate pro-inflammatory signaling through NFκB and JNK-mediated pathways (15).  In a similar 
manner, circulating LPS, upregulated in obese individuals purportedly via the effects of high-calorie 
diets on gut microbiota (65), stimulates its receptor TLR4 and induces NFκB-mediated 
inflammation.  Activation of signaling through these pathways mediates release of pro-
inflammatory cytokines including TNF-α, IL-6, and IL-1β and further propagates the inflammatory 
response in a feed-forward manner by acting on macrophages and surrounding cells (23). 
 Cytokines released from activated macrophages and other adipose-associated cells by the 
above mechanisms play a major role in the pathogenesis of many obesity-associated diseases.  In 
addition to the induction of insulin resistance through JNK-mediated phosphorylation of IRS-1 as 
stated above, pro-inflammatory cytokines are thought to play a role in the induction of depression 
through the actions of IL-1β on the central nervous system (74).  Additionally, the level of acute 
19 
 
phase reactant CRP, secretion of which is induced by IL-6 in the liver,  is important independent 
biomarker for the development of cardiovascular disease (55) and diabetes (23). 
 The role of macrophage phenotype in obesity is also under intense study.  Adiposity induces 
greater expression of leptin, an appetite-regulating hormone responsible for inhibiting food intake 
(62).  However, leptin also plays a number of roles in immunity, including stimulation of neutrophil 
activation (14), cytokine production by monocytes and macrophages (90), as well as increasing 
phagocytosis by APCs and stimulating natural killer (NK) cell activity (62).  Additionally, leptin 
drives the induction of a shift to TH1-type adaptive immunity in the adipose tissue (66).  TH1 
responses are associated with increased expression of interferon (IFN)-γ, a cytokine which induces 
macrophages to take on a pro-inflammatory, “classically-activated macrophage (CAM)” phenotype 
(41).  In contrast, resident macrophages in lean adipose tissue have an anti-inflammatory, 
“alternatively-activated macrophage (AAM)” phenotype, potentially stemming from signaling via 
IL-13 released from healthy adipose tissue (77).   
 Reduction of anti-inflammatory mediators also plays a role in the inflammatory state of 
obesity.  Adiponectin, an adipocyte-expressed cytokine, is detectable at high levels in the blood and 
is decreased in obese compared to lean individuals (89).  Adiponectin is known to stimulate 5' 
adenosine monophosphate-activated protein kinase (AMPK) activity through activation of the 
adiponectin 1 receptor (115), increasing insulin sensitivity and improving metabolic dysfunction.  
Additionally, adiponectin acts as a collectin, binding to apoptotic cells and inducing uptake 
(efferocytosis) of apoptotic bodies by macrophages (102).  As previously stated, efferocytosis of 
apoptotic cells induces a phenotypic switch in macrophages, suppressing pro-inflammatory TNF-α 
production and stimulating anti-inflammatory IL-10 production (27).  This function is impaired in 
macrophages isolated from obese mice (60), an observation which may be mediated by reduced 
adiponectin seen in obesity as stated above.  Additionally, adiponectin may signal macrophages  
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directly via receptor-mediated pathways, although these anti-inflammatory mechanisms are not yet 
well understood (79). 
 Thus, in these ways, chronic low-grade inflammation is thought to play a major role in the 
pathogenesis of obesity-related conditions including cardiovascular disease and insulin 
resistance/diabetes.  Additionally, increased inflammation resulting from obesity may be a root 
cause of other conditions associated with obesity, including, notably, impaired wound healing.  
Therefore, the effect of obesity on wound healing, and its relationship with increased local and 
systemic inflammation, is an active area of research at the present time.  
 
Figure 2.2.  Mechanisms of adipose tissue inflammation in obesity. Abbreviations can be found in Appendix A. 
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2.3  Obesity and Wound Healing 
 Numerous studies have noted a relationship between obesity and impaired wound healing.  
These studies can be broken down into several groups based on intervention.  Obesity is generally 
induced in rodents either by feeding of a high-fat diet (HFD, typically 30-60% of total kcal from fat) 
or be means of genetic manipulation.   
2.3.1  High-Fat Diet Studies 
 Rats fed a high-fat diet consisting of 30% total kcals from fat for 15 weeks had significantly 
higher percentage of initial wound area remaining at 14 and 21 days post-wounding compared to 
non-obese control mice (72).  Re-epithelialization of the wound area was also impaired in high-fat 
diet-fed mice, and the control group showed greater fibroblast infiltration at 21 days post-
wounding compared to their obese counterparts.  In a similar study, rats fed a high-fat diet for 4 
months had reduced wound strength compared to non-obese controls in an experimental model of 
abdominal laparotomy, which induces a skin wound as well as scar formation (9).  In a study in 
female mice, those rodents fed a reduced-calorie diet healed faster than either ovariectomized 
(OVX) or intact mice fed a HFD, although presence of estrogen was partially protective against 
delayed wound healing, possibly as a result of increased weight gain in the OVX mice (49).   
2.3.2  Genetic Obesity Studies 
 In a comparative study, HFD-fed mice were tested alongside genetically-obese ob/ob mice 
to determine wound closure rates relative to non-obese controls.  Although ob/ob mice gained 
much more weight than HFD-fed mice, both groups had greatly impaired wound healing relative to 
non-obese normal C57Bl/6 control mice (94).  In a model of diabetic foot ulcers, genetically obese 
db/db mice had greatly delayed healing compared to both +/+ and db/+ controls, with both non-
diabetic strains having 100% wound closure at day 21 compared to 50% closure at the same time 
point in db/db mice (106).  Similarly, genetically obese Zucker rats had larger wound size and 
reduced wound strength in a model of laparotomy wound healing at 28 days post-operation (114).   
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2.3.3  Mechanisms 
 Due to the deficiencies in wound healing in obesity models as noted above, a number of 
studies have been conducted in an attempt to explain the mechanism(s) behind this phenomenon.  
Because of the pivotal role that inflammation plays in healing, and given the well-established 
aberrant inflammation present in obesity as described above, much of the work in this area has 
focused on the effects of inflammation on healing in obesity.  The results of these experiments will 
be described herein.  
 Early evidence indicated that foot ulcers, a type of chronic non-healing that is responsible 
for a number of amputations annually, were associated with an increase in wound-adjacent 
inflammatory cell accumulation in obese patients with diabetes (30, 86).  However, in diabetic 
patients, leukocyte function is impaired (21, 71), which can predispose such individuals to infection 
even in the presence of abnormal wound inflammation.   These studies provided evidence that 
aberrant inflammation in obesity and diabetes is associated with, and can be detected near the site 
of impaired wound healing, thus paving the way for mechanistic studies using animal models of 
these conditions.  In diabetic mice and humans, delayed wound healing is associated with decreases 
in most growth factors including TGF-β, PDGF, and IGF-1 as well as increases in pro-inflammatory 
cytokines such as TNF-α and IL-1β (10).  Additionally, impaired healing is associated with 
dysregulation of collagen turnover including increased MMP and decreased TIMP activity  and 
decreases in angiogenesis, granulation tissue formation, and collagen deposition (10).  Many of 
these processes are thought to result from aberrant inflammation, aspects of which will be 
discussed below. 
 In genetically-diabetic db/db mice, impaired wound healing is associated with increased 
and prolonged expression of inflammatory chemokines including MCP-1 and macrophage 
inflammatory protein (MIP)-2, and expression of these chemokines results in increased levels of 
PMN and macrophage infiltration into the wound site (110).  Due to the leptin-resistant nature of 
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db/db mice, and the defects in wound healing seen in leptin-deficient ob/ob mice, Goren et al. (42) 
hypothesized that leptin plays a role in the inflammation-induced defects in healing seen in both 
types of genetically-obese mouse models.  Administration of leptin to ob/ob mice sped healing, and 
was associated with a reduction of PMN but not macrophage infiltration into the wounds of the 
mice (42).  Additionally, leptin administration attenuated PMN-associated MIP-2 expression, with 
no change in MCP-1 expression.  This suggests that, at least in a leptin deficient model of obesity, 
PMNs play a larger role in healing response than do macrophages, especially at early time points, a 
finding that underscores the importance of proper resolution of inflammation in healing.  This is 
supported by the finding the neutrophil depletion in diabetic mice sped healing (24), evidence that 
PMNs may be important for pathogen defense in wounded tissue yet ultimately detrimental to the 
healing process in sterile wounds. 
 In a similar study, wounds from ob/ob and db/db mice were analyzed for expression levels 
of cyclooxygenase (COX)-1 and COX-2, both regulators of prostaglandin (PG) synthesis at the 
wound site (54).  COX-2-induced PG synthesis is quickly upregulated under inflammatory 
conditions (98), while PG synthesis controlled by COX-1 has been shown to be important for 
undisturbed healing (53).  Compared to normal wild-type mice, skin wounds of ob/ob and db/db 
mice showed overexpression of COX-2 and reduced expression of COX-1, especially later (13 days 
post-wound) in the repair process (54).  Wound-associated macrophages were the major producers 
of COX-2 in the diabetic mice, suggesting that improper resolution of inflammation may lead to 
prolonged, aberrant macrophage activation in delayed-healing wounds. 
 More recently, Goren et al. directly investigated the role of inflammation in delayed healing 
in ob/ob mice using neutralizing antibodies against TNF-α and F4/80, a macrophage cell surface 
protein, to dampen systemic inflammation in an attempt to speed healing (44).  Although these 
treatments did not reverse symptoms of the metabolic syndrome seen in these mice, healing rate 
was markedly increased in the antibody-treated mice.  Additionally, inflammation in these mice was 
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decreased by antibody treatment, as mRNA levels of IL-1β, TNF-α, and COX-2 were reduced and 
numbers of circulating monocytes as well as numbers of wound-associated macrophages were also 
decreased.  Likewise, TNF-α impairs insulin signaling in wounds in ob/ob mice (43) and increases 
fibroblast apoptosis at the wound site in db/db mice (96).  These data suggest that wound 
inflammation plays a major role in wound closure in these mice. 
 Still more recent evidence has supported the hypothesis that leukocyte dysfunction 
mediates delayed healing in obesity and diabetes.   As stated above, macrophages are responsible 
for clearing apoptotic PMNs from the wound site in order for healing to progress.  However, an 
increase in apoptotic cells has been noted in both genetically-diabetic db/db mice as well as diabetic 
humans (60).  These apoptotic cells were shown to be PMNs, and wound-associated macrophages 
isolated from db/db mice were unable to clear apoptotic cells in vitro, suggesting that macrophage 
dysfunction can prolong the inflammatory state in diabetic wounds, as efferocytosis of apoptotic 
PMNs is potentially necessary for resolution of inflammation (27). 
 Interestingly, a comparative study of genetically-diabetic and HFD-fed mouse models of 
obesity indicated that, while the genetically-obese ob/ob mice developed chronic wounds, HFD-fed 
obese mice did not develop chronic wounds, although healing was delayed in this model (93).  
Accordingly, while ob/ob and db/db mouse models are preferred for studies of healing mechanisms 
of chronic wounds such as diabetic leg ulcers, wounds of HFD-fed mice may be much more suited to  
the study of acute but still-delayed healing of wounds such as those induced by bariatric or other 
surgeries in obese individuals. 
 
2.4  Obesity and Exercise 
 Exercise training influences obesity in a number of ways.  Weight gain occurs when daily 
energy expenditure is less than daily caloric intake (50), known as positive energy balance.  In 
developed countries, increasing consumption of high-fat and high-calorie foods as well as 
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decreasing levels of exercise have played major roles in the ever-increasing rates of obesity (83).  
Increasing energy expenditure through exercise as well as reducing energy intake through diet are 
widely known to reduce body fat and improve health in individuals.  However, exercise also has a 
number of other beneficial effects on the comorbidities associated with obesity, including on 
inflammation and therefore, potentially, on wound healing. 
2.4.1  Inflammation 
 It is well established that increased obesity as estimated by BMI is associated with 
increased levels of systemic inflammation.  NHANES data indicates that higher BMI is associated 
with higher CRP, and that CRP levels are likely to be highest in individuals with diabetes (35).  
Similarly, larger waist-to-hip ratios are associated with higher CRP values, independent of BMI 
(108).  Further, weight loss induced by diet with no change in physical activity effectively reduced 
CRP levels in postmenopausal obese women (103).  Thus, there is considerable interest in 
developing the proper weight loss strategies to reduce inflammation in these obese populations, as 
inflammation is a risk factor for a number of obesity-related comorbidities including cardiovascular 
disease (87). 
 It has been shown in a number of studies that weight loss through diet and/or exercise is 
effective at reducing systemic inflammation in obese individuals.  A multidisciplinary weight loss 
program for obese women which included diet and exercise as well as behavioral counseling was 
effective at reducing systemic cytokine and adhesion molecule expression levels (117), both of 
which are associated with inflammation.  Similarly, weight loss induced by diet and increased 
physical activity in premenopausal obese reduced serum levels of IL-6, IL-18, and CRP (26), each a 
measure of systemic inflammation.  This is further supported by evidence that increased leisure-
time physical activity is associated with reduced systemic inflammatory markers including IL-6 and 
CRP, an association that is partially explained by reduced obesity in the study subjects (84).  
However, not all such studies support the above conclusions, as weight loss induced by diet or 
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diet+exercise was able to reduce circulating markers of inflammation including MCP-1, MIP-1α, IL-
15, and IL-18 in obese subjects, while exercise alone was not sufficient to induce these changes 
(16).  However, it should be noted that the degree of weight loss in the exercise group was nearly 4-
fold lower (3.5 kg lost vs. 12 kg) than in the diet and diet+exercise groups, suggesting that the 
magnitude of weight loss may be most important regardless of the method by which weight loss is 
achieved. 
 Interestingly, exercise training without weight loss did not reduce levels of systemic 
inflammatory markers including CRP, IL-6, and soluble TNF-α receptor (sTNFR)-1, although diet-
induced weight loss did attenuate inflammation in this study (73).  Likewise, exercise training 
which resulted in modest changes in fitness parameters including body composition and insulin 
sensitivity in obese individuals was not effective in lowering systemic CRP.  In contrast, a similar 
study in obese postmenopausal women found that diet + exercise, but not diet alone, was sufficient 
to lower systemic inflammatory marker CRP as well as cytokines TNF-α, IL-6, and their soluble 
receptors (116).  Another study found that 12 weeks of exercise training without weight loss 
reduced serum IL-6 but not CRP in obese and obese+diabetic men (20).   
 Reductions in inflammation in obesity are also associated with improvements in overall 
health.  Diet- and exercise-induced weight loss decreased plasma proinflammatory cytokine levels 
and improved insulin sensitivity in obese postmenopausal women (88).  Exercise also improved 
endothelial function and reduced systemic inflammation in obese subjects (58).  In patients with 
impaired glucose tolerance or type 2 diabetes (T2D), 4 weeks of exercise training both improved 
glucose metabolism and insulin sensitivity and was associated with increases in systemic levels of 
anti-inflammatory mediators IL-10 and adiponectin (76).  In overweight and obese men, exercise 
training reduced blood low density lipoprotein (LDL) as well as high density lipoprotein (HDL) and 
decreased the inflammatory index of HDL, converting the actions of HDL from pro-inflammatory to 
anti-inflammatory (85).  Likewise, weight loss induced by diet and exercise training in obese 
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subjects decreased arterial stiffness and improved metabolic health, a finding that was associated 
with significant reductions in serum CRP (40).  
 Given the cross-sectional and longitudinal data demonstrating exercise and weight loss 
benefits on inflammation in obesity, there is considerable interest in discovering the mechanisms 
behind these results.  Many of these studies have focused on localized inflammation in the WAT.  
The prevailing hypothesis of these studies is that exercise will reduce inflammation as measured by 
various cytokine and adipokine markers in WAT, and that this reduction will be associated with 
decreased systemic inflammation as well as with increased overall health markers including insulin 
sensitivity, glucose metabolism, and cardiovascular health. 
 In severely obese subjects, exercise training reduced systemic and WAT inflammation as 
measured by cytokine, chemokine, and CRP levels (12).  Additionally in these subjects, macrophage 
infiltration into WAT seemed to be reduced as gene expression of macrophage markers CD14 and 
CD68 was decreased.  In obese individuals, 8 weeks of exercise training reduced WAT gene 
expression of IL-18, a finding that was positively correlated with insulin resistance (64).  Similarly, 
6 weeks of exercise in mice fed a HFD reversed the HFD-induced increase in inflammatory markers 
TNF-α, MCP-1, and IKKβ compared to mice fed a low-fat diet (LFD) for the same time period (11). 
 In a comparative study (107) in mice testing the effects of diet and exercise, mice were fed a 
HFD for 6 weeks, after which they were placed on LFD or remained on HFD and were assigned to 
either exercise or sedentary groups for 12 weeks.  Exercise and/or LFD reduced adipose markers of 
inflammation including MCP-1, F4/80, TNF-α, and leptin, and neither intervention appeared to be 
more beneficial than the other.  Interestingly, despite the increased basal inflammation seen in 
most animal models of obesity, macrophage response to antigen stimulation is impaired in obese 
rats, and exercise training partially ameliorates this impairment by increasing the inflammatory 
response of macrophages when presented with an antigenic challenge (68).  Recently, exercise in 
HFD-fed mice was shown to induce a macrophage phenotypic switch from an M1 (classically-
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activated, pro-inflammatory) to an M2 (alternatively-activated, anti-inflammatory) type in WAT 
(57), suggesting a possible mechanism by which exercise reduces inflammation in WAT.  However, 
it should be noted that this study, as well as many of the studies referenced above, used only gene 
expression analysis of M1 and M2 markers, a method which is of questionable validity as no studies 
to date have assessed the impact of exercise on expression of most of these genes at a single-cell 
level.   
 Changes in inflammation at other locations in the body may play a role in the observed 
effects of exercise on systemic inflammation in obese individuals.  Lambert et al. found that 
exercise- but not diet-induced weight loss decreased gene expression of TLR4, IL-6, and TNF-α in 
skeletal muscle of obese subjects (63).  More recently, exercise has been shown to reduce 
circulating LPS as well as protein and messenger RNA (mRNA) levels of TLR4 in liver, muscle, and 
WAT of HFD-fed mice, a finding that was associated with decreased signaling through JNK and 
NFκB pathways and an increase in insulin sensitivity (78).  Thus, further work in the area of 
exercise and inflammation in obesity should focus not only on local inflammation in WAT but also 
on inflammation at other peripheral sites. 
2.4.2  Wound Healing 
 Given the significant effects of exercise on inflammation in obese individuals, both 
systemically and locally, a logical hypothesis would be that exercise training could reduce the 
aberrant inflammation seen in wound tissue in obese individuals and thereby ameliorate the delays 
in wound healing often seen in this population.  However, to date, no studies have examined the 
role of exercise on wound healing using an obesity model, either in humans or in experimental 
animals.  However, a small number of studies have focused on the role of exercise in modulation of 
the wound healing process using an aging model of delayed healing.  As aged individuals show 
chronic elevation of inflammation similar to that seen in obese individuals (61), findings from these 
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studies are important data points by which to generate a working hypothesis for extension of these 
studies to an obesity model of wound healing. 
 In a study utilizing older adults (25), cutaneous wounds were applied one month following 
onset of the exercise intervention.  Wound healing was then assessed until total closure of the 
wound.  Exercisers healed significantly faster than sedentary subjects (mean time to total closure 
29 days vs. 39 days, respectively).  No molecular measures of wound status were taken during the 
course of the study, thus no real inferences can be drawn as to the mechanisms behind these 
changes.  However, this study was the first to definitively shown an exercise effect on healing of 
cutaneous wounds. 
 More recently, a study from our laboratory utilizing aged mice (59) was performed to test 
the potential mechanisms by which exercise might speed healing in aged individuals.  Similar to the 
Emery study referenced above (25), if was found that exercise significantly sped healing compared 
to healing rate in sedentary controls.  Interestingly, the major differences in healing rate between 
groups occurred early (1-5 days) post-wounding, indicating that exercise may be exerting its effects 
on healing at these time points, which correspond to the inflammatory phase of healing as 
discussed previously.  Thus, the authors assessed the inflammatory status of the wound using gene 
and protein expression for selected pro-inflammatory cytokines and chemokines.  TNF-α wound 
protein expression was reduced at days 3 and 5 post-wounding, with a nearly-significant reduction 
at day 1 post-wounding as well.  Likewise, MCP-1 protein was reduced at days 1 and 3 post-
wounding, while keratinocyte chemoattractant (KC) protein, the mouse equivalent to the human 
neutrophil chemokine IL-8, was reduced at days 3 and 5 post-wounding.  However, there were no 
differences in F4/80 gene expression or in wound myeloperoxidase (MPO) activity, respectively 
proxy measures for macrophage and neutrophil wound infiltration.  Thus, the data from this study 
(59) suggest that exercise speeds wound healing rate in aged mice, and that this is associated with 
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reduced inflammation despite no significant changes in inflammatory cell infiltration; although this 
was not assessed directly. 
 The results of the above studies shed light on potential mechanisms by which exercise 
might speed wound healing in obese individuals.  The field of exercise research in cutaneous wound 
healing is in its infancy, and significant work remains to be done using obesity, aging, and other 
models of delayed healing.  Interestingly, the Keylock et al. study discussed above (59) found a 
nearly-significant effect (p = 0.10) of exercise on healing rate in young, healthy mice, suggesting 
that exercise might speed healing even in those without aberrant basal inflammation, although a 
mechanism by which this occurs is not clear at this time. 
 
2.5  Summary 
 Complications in wound healing are common in obese patients (111).  This includes both 
delayed closure of acute wounds as well as failure to heal in chronic wounds.  Aberrant 
inflammation is thought to play a major role in delayed healing in obesity (86).  Obese individuals 
show elevated levels of markers of systemic inflammation (35), a phenomenon that is thought to be 
mediated by increased inflammation in the WAT (37).  Exercise is known to reduce inflammation 
both systemically (26, 84) and locally (107) in obesity.  Additionally, exercise has been shown to 
speed healing in aged mice (59) and in older adults (25), a finding that was associated with reduced 
wound tissue inflammation in the former study.  Therefore, it is possible that exercise training will 
have a similar effect on healing in obese individuals, speeding healing via a reduction in 
inflammation in the wound tissue. 
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CHAPTER 3 
EXPERIMENTAL DESIGN AND METHODOLOGY 
 
 Many of the protocols outlined in this study are identical to or similar to those used 
previously in the Woods lab and published in Keylock et al. (6) in a study on wound healing in aged 
mice.   These methods were developed to parallel those used in models of restraint stress, as such 
interventions have been shown to delay healing in mice (8).  Exercise and restraint stress in these 
studies have been shown to differentially affect healing with exercise speeding healing and 
restraint stress delaying healing, although both tended to decrease wound inflammation.  A 
potential explanation for this is that the exercise intervention was carried out in old mice, which are 
representative of a population known to have chronic elevation of inflammatory mediators (7).  In 
contrast, the restraint stress studies were conducted in young mice, thus a reduction in 
inflammation in this population may be detrimental to healing as some inflammation is necessary 
for the healing process to occur (5).  As obesity is known to be associated with higher inflammatory 
levels similar to those seen in aged individuals (3, 4), the exercise intervention in this study was 
kept as closely as possible to that in the Keylock et al. study (6) as it is hypothesized that exercise in 
obese mice will cause similar improvements in both wound healing and wound inflammation to 
those seen in aged mice. 
 
3.1  Experimental Design 
3.1.1  Mice 
 Female C57Bl/6J (Jackson Labs, Bar Harbor, ME) were used for all aspects of this study.  
These mice were chosen for several reasons.  Female mice were previously used in wound healing 
studies in both the Keylock study on exercise and aged mice (6) and the Padgett study on restraint 
stress (8) described above.  Additionally, female mice seem anecdotally to respond better to 
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treadmill training and thus offer an advantage in this respect as obese mice sometimes have 
difficulties adhering to a treadmill running protocol.  C57Bl/6J mice were chosen as they are the 
most common research model for DIO and respond to high-fat diet better than other common 
mouse strains such as Balb/cByJ (9).  All mice in this study were 6-8 weeks of age at the onset of the 
feeding intervention. 
3.1.2  Housing and feeding protocols 
 All mice were housed in an AAALAC-approved animal facility on the University of Illinois at 
Urbana-Champaign (UIUC) campus.  All procedures performed on the mice in this study received 
approval from the UIUC Institutional Animal Care and Use Committee (IACUC) prior to the onset of 
the study.  Procedures for this study were performed on IACUC protocols 07276 and 11024.  Mice 
were housed for one week after delivery from Jackson Laboratories (Bar Harbor, ME) and allowed 
to acclimate to the facility.  Food and water was given ad libitum, and the housing room was on a 
reverse light-dark cycle with dark cycle from 09:00 to 21:00 hours daily.  Cages were changed 
weekly by animal care staff, and mice were removed from the room only for the wounding and 
wound closure analysis procedures until euthanasia. 
 After the one week acclimation period, mice were placed on a high-fat experimental diet 
(Research Diets, New Brunswick, NJ) which contains 45% of total kcal from fat.  Mice were given ad 
libitum access to this diet and were fed for a total of 16 weeks prior to the beginning of the exercise 
intervention.  Control mice and young non-obese mice were fed a low-fat, standard chow diet 
(Harlan, Indianapolis, IN) which contains 4.5% of total kcal from fat.  Food intake and body weight 
were monitored monthly over the course of the feeding period. 
3.1.3  Exercise training protocol 
 The exercise training protocol was identical to that described in Keylock et al. (6).  Mice 
were exercised on a motorized treadmill (Jog A Dog, Ottawa Lake, MI) at 15 m/min and 5% grade 
for 30 minutes per day.  The treadmill is divided into 20 lanes in a 4 across × 5 down arrangement, 
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and sponges are placed at the back of the treadmill to prevent injury to the mice.  Mice run 
beginning at 08:30 as previous anecdotal experience suggests that adherence to the training 
protocol is best in these mice when they are exercised in the last 30 minutes of the light cycle.  
Sedentary mice remained in their cages and were exposed to treadmill noise and vibrations during 
the exercise portion of the study.   
3.1.4  Wounding protocol 
 The cutaneous punch biopsy skin wound is used in a number of studies including the 
Keylock and Padgett studies referenced above (6, 8).  Mice were anesthetized using inhaled 
isoflurane in oxygen at a flow rate of 2-3 L/min for the wounding procedure.  Prior to wounding, 
mice were shaved on the dorsum, and the cleared area was cleaned with 3 alternating scrubs of 
Betadine® (Purdue Products L.P., Stamford, CT) and ethanol prior to wounding.  Wounds were 
made by folding over the skin, and a 6mm punch biopsy instrument (HealthLink, Jacksonville, FL) 
was used to create two full-thickness dermal wounds.  Two wounds were created on mice used for 
wound closure analysis as described below.  Four wounds were created on mice used for analysis of 
molecular markers of healing such as inflammation, cell number and function, etc.  This wounding 
method is well-characterized and is fully described in DiPietro & Burns’ Wound Healing: Methods 
and Protocols (2).   
 The wounding procedure takes approximately 1 minute, and mice were returned to their 
cages to recover post-wounding.  Recovery from isoflurane takes approximately 30 seconds to 1 
minute.  No post-wound analgesic was used as such treatments speed healing and reduce 
inflammation (1) and would confound the expected results for this study.  Mice were monitored for 
signs of distress post-wounding (lethargy, decreased grooming, deceased food consumption/body 
weight), and consultation with veterinarians from the UIUC Division of Animal Resources (DAR) 
was sought in such cases.  Mice that show signs of infection (e.g. pus, swelling, redness) of the 
wound site were euthanized as required by DAR policy. 
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3.1.5  Euthanasia and tissue processing 
 Mice were euthanized via rapid carbon dioxide (CO2) asphyxiation.  As soon as possible 
after euthanasia, wounds were harvested from the mice using an 8mm punch biopsy needle 
(HealthLink, Jacksonville, FL) and frozen on dry ice or fixed in formalin for histology.  Frozen 
wound tissue was stored at -80oC until processing.  Blood was collected from the inferior vena cava 
and cooled in heparinized microfuge tubes on ice.  Collected blood was centrifuged at 4oC at 1100×g 
for 10 minutes, and plasma was aliquoted into labeled tubes and stored at -20oC until analysis.  
Epididymal adipose tissue was excised, frozen on dry ice, and stored at -80oC until processing.  
Remaining carcasses were frozen and later incinerated.  Spleens were weighed as a screening 
measure for splenomegaly, a sign of systemic infection. 
3.1.6  Obesity and metabolic function markers 
 Mice were assessed for obesity and glucose intolerance in several ways.  Body weights were 
collected at the beginning of the study, prior to the onset of exercise, and immediately prior to 
euthanasia for comparison of HFD- and LFD-fed groups.  Glucose tolerance testing (GTT) was 
performed on a subset of mice in each group 1 week prior to the exercise intervention according to 
recommendations provided by Jackson Laboratories.  Mice were fasted overnight prior to GTT.  At 
time 0, blood glucose was measured by tail nick using an automated glucometer after which mice 
were given 1g/kg glucose intraperitoneally.  Blood glucose was similarly measured at 30, 60, 90, 
and 120 minutes post-injection.  For the tail nick, a small portion of the tip of the tail was cut off 
using scissors, and blood (1-2 drops) was collected.  Clotting takes place within less than 2 minutes 
post-nick, and only a small amount of blood is lost.  GTT values were compared between HFD- and 
LFD-fed groups as a marker of metabolic derangement induced by the HFD.  In a separate study, a 
subset of mice were analyzed for glucose tolerance as described above at day 1 post-wounding.  
This was done to determine if the exercise intervention increased insulin sensitivity in exercised 
compared to sedentary mice. 
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3.1.7  Statistical analysis 
 All analyses were performed using SPSS version 19 (IBM, Somers, NY).  Differences in body 
weight and food intake between groups were measured by univariate analysis of variance 
(ANOVA).  GTT responses were assessed by measurement of area under the curve (AUC) of the 
glucose response and group differences were determined via ANOVA.  Graphs of data were 
produced using GraphPad Prism 5 software (GraphPad Software Inc., La Jolla, CA).  A significance 
level of α=0.05 was used for all statistical measures.  Further statistical procedures for wound 
analysis are described in each relevant section below. 
 
3.2  Analysis of Wound Healing Kinetics 
 The procedure for the analysis of the effects of exercise on wound healing kinetics is 
outlined in Figure 3.1.  Exercise training was performed as described in section 3.1.3 for 3 days 
prior to wounding.  On the 
fourth day, referred to 
hereinafter as day 0, two 
wounds were applied as 
described in section 3.1.4 at 1 
hour after completion of the 
normal exercise bout.  
Following this, mice were exercised daily for 5 days post-wounding as described above.  Thus, the 
study includes a total of 9 days of exercise (3 days prior to wounding, on the day of wounding, and 5 
days post-wounding).  DIO mice that remain sedentary during this time period served as controls.  
Additionally, LFD-fed exercised and sedentary mice were compared to exercised and sedentary DIO 
mice to ensure that the HFD feeding regimen slowed healing as intended in these mice. 
3.2.1  Photography 
Figure 3.1  Wound closure study experimental design.  Wounds are 
applied on day 0.  Mice run for 3 days prior to wounding and 5 days after 
wounding.  Wounds are photographed  for 10 days post-wounding. 
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 On day 0, immediately after the wounding procedure, wounds were photographed while the 
mouse was under anesthesia.  Following this, healing was assessed for 10 days (days 1-10 post-
wounding) photographically.  Approximately 1 hour after exercise, mice were briefly anesthetized 
via inhaled isoflurane as during the wounding procedure, and wounds were photographed.  A 10 
megapixel digital single lens reflex 
camera (Nikon Corp., Tokyo, Japan) 
with a zoom lens (Nikon Corp., 
Tokyo, Japan) set at a focal length 
of 35mm and focused at closest 
possible focusing distance (0.28m, 
magnification 0.14×) was attached 
to a tripod with a horizontal 
mounting arm (Feisol, Taipei, 
Taiwan) for wound photography.  A 
standard 8mm dot was included in 
each photo as a reference and used to normalize each photo to ensure that minor variations in day-
to-day placements of the camera did not skew the results.  The photography setup, including 
representative images of the wound site and reference dot, is shown in Figure 3.2. 
3.2.2  Photoplanimetry 
 Wound area was assessed using photoplanimetry in ImageJ 1.42q software (NIH, Bethesda, 
MD).  Wound areas and 8mm reference dots were traced, and wound areas were normalized first to 
the reference dot and then to the normalized wound area of the mouse on day 0.  Thus, the value is 
expressed as a percent baseline with the normalized wound area for each mouse equal to 100% on 
day 0 and decreasing to 0% at full closure.  Wounds were followed photographically for 10 days as 
Figure 3.2  A) Representative photograph of camera setup for wound 
closure analysis. B) Representative photograph of cutaneous wound on 
mouse. C) 8mm reference dot used to standardize wound area measures. 
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described.  Wounds were then visually inspected at day 12, 15, and 20 post-wounding for 
assessment of full closure. 
3.2.3  Statistical analysis 
 All analyses were performed using SPSS version 19 (IBM, Somers, NY).  Wound healing 
kinetics were assessed via repeated measures ANOVA, with separation of means using Tukey’s 
post-hoc analysis in the event of a significant main effect of exercise or interaction effect (exercise × 
time).  Chi-squared tests were used to determine if differences exist between groups in percentage 
of mice with fully healed wounds at days 12, 15, and 20 post-wounding.  A significance level of 
α=0.05 was used for all statistical measures.   
 
3.3  Analysis of Wound Inflammation 
 The procedure for the analysis of the effects of exercise on wound inflammation in this 
study is outlined in Figure 3.3.  
Exercise training was performed 
as described in section 3.2.  
Subsets of mice were euthanized 
at days 1, 3, and 5 post-
wounding, and wounds were 
harvested as described in 
section 3.1.5 and stored until 
processing.  Frozen wound tissue was used for gene expression analysis using RT-PCR and protein 
analysis using ELISA.  Additionally, wound tissue was stored for immunohistochemical analysis of 
cell infiltration. 
3.3.1  Gene expression analysis 
Figure 3.3  Wound inflammation study experimental design.  Wounds are 
applied on day 0.  Mice run for 3 days prior to wounding and 1-5 days after 
wounding.  Subsets of mice are euthanized at days 1, 3, and 5 post-
wounding and wounds are harvested for analysis of wound site 
inflammation. 
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 Total RNA was isolated from frozen tissue using Trizol® (Invitrogen, Carlsbad, CA) 
according to the manufacturer’s instructions.  RNA purity was assayed using an automated micro-
volume Nanodrop spectrophotometer (Thermo Fisher, Waltham, MA).  RNA samples with 260/280 
ratios near 2.0 were used for further analyses.  Isolated RNA was reverse-transcribed to cDNA using 
a high-capacity cDNA reverse transcription kit (Applied Biosystems, Carlsbad, CA) according to 
manufacturer’s instructions.  The resulting cDNA was stored at -20oC until RT-PCR analysis for gene 
expression of selected inflammatory markers.  Complete protocols for RNA isolation, assessment of 
RNA purity, and cDNA reverse transcription are available in Appendix B. 
 PCR was performed on isolated cDNA at the Functional Genomics Laboratory at UIUC.  
Samples were loaded in 384-well microtiter plates for analysis.  Samples were run in duplicate.  For 
each sample, 1 μl of cDNA was diluted in 3.5 μl of nuclease-free water and added to the plate.  A 
master mix consisting of 5 μl of TaqMan (Applied Biosystems, Carlsbad, CA) and 0.5 μl of the primer 
of interest per sample was prepared, and 5.5μl of this master mix was added to each well.  Once 
prepared, the plate was sealed and stored at 4oC until analysis.  The plate was run on a high-
throughput real-time PCR machine (Applied Biosystems, Carlsbad, CA) according to the instructions 
provided by the Functional Genomics Laboratory staff.  Protocols for RT-PCR plate preparation and 
analysis are provided in Appendix B. 
 Gene expression was analyzed for a number of inflammatory markers.  Pro-inflammatory 
cytokines TNF-α, IL-1β, and IL-6 and macrophage and neutrophil chemokines MCP-1 and KC were 
assessed.  Anti-inflammatory cytokines IL-10 and TGF-β were also measured.  Additionally, 
markers of proliferation and tissue remodeling were measured.  All TaqMan gene expression assay 
primers were purchased from Applied Biosystems (Carlsbad, CA).  Expression of β-actin was used 
as the housekeeping gene.   
3.3.2  Protein expression analysis 
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 In addition to gene expression analysis, protein levels in wound tissue were assessed to 
confirm that genes for which significant expression differences are found were being translated 
differentially as well.  Protein was isolated using Trizol® (Invitrogen, Carlsbad, CA) according to 
manufacturer’s instructions.  Isolated protein concentration was determined via a commercial 
protein assay kit (Biorad, Hercules, CA) according to manufacturer’s recommended protocol.  
Expression of pro-inflammatory cytokines TNF-α and IL-1β as well as anti-inflammatory cytokine 
IL-10 in isolated wound protein were measured via ELISA (R&D Systems, Minneapolis, MN; 
Peprotech, Rocky Hill, NJ) according to the provided protocols.  Complete protocols for protein 
isolation, assessment of protein concentration, and ELISA analysis of cytokine concentration are 
provided in Appendix B.  
3.3.3  Statistical analysis 
 All analyses were performed using SPSS version 19 (IBM, Somers, NY).  Relative fold change 
in gene expression was calculated using the delta-delta Ct method with the sedentary mice serving 
as the reference group.  Kinetics of gene or protein expression and between group differences were 
analyzed via two-way ANOVA (group × day) with Tukey’s post-hoc analysis in the event of a 
significant interaction or a significant main effect of exercise or day.  A significance level of α=0.05 
was used for all statistical measures.   
 
3.4  Analysis of Cell Number  
3.4.1  Histology 
 Frozen tissues were embedded in O.C.T. compound (Tissue-Tek, Sakura Finetek, Torrance, 
CA) and sectioned using a cryostat at -25oC.  Tissue sections were stained for macrophage number 
using a primary antibody against CD68 (Abcam, Cambridge, MA) and an AlexaFluor 488-conjugated 
secondary antibody (Invitrogen, Grand Island, NY) and imaged using a fluorescent microscope at 
20X magnification.  Macrophage number was assessed in a blinded manner and was expressed as 
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the average CD68+ cell count in 1-3 randomly-chosen high-power fields.  Protocols for 
immunofluorescence staining can be found in Appendix B. 
3.4.2  Gene expression analysis 
 Markers of macrophage infiltration and phenotype were measured, including F4/80 for 
macrophage infiltration and cluster of differentiation (CD)-206 and found in inflammatory zone 
(FIZZ)-1 as markers of alternative macrophage activation.  All TaqMan gene expression assay 
primers were purchased from Applied Biosystems (Carlsbad, CA).  Expression of β-actin was used 
as the housekeeping gene.   
3.4.3  Statistical analysis 
 All analyses were performed using SPSS version 19 (IBM, Somers, NY).  Relative fold change 
in gene expression was calculated using the delta-delta Ct method with the sedentary mice serving 
as the reference group.  Kinetics of cell number and  gene expression and between group 
differences were analyzed via two-way ANOVA (group × day) with Tukey’s post-hoc analysis in the 
event of a significant interaction or a significant main effect of exercise.  A significance level of 
α=0.05 was used for all statistical measures.   
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CHAPTER 4 
RESULTS 
 
4.1 Descriptive Data 
4.1.1 Body Weight and Food Intake 
 Body weights at arrival at our facility did not differ between HFD and Chow-fed groups.  By 
week 16 of the feeding intervention, HFD body weights were significantly higher than those of the 
chow group, as expected (Table 4.1).  Food intake in grams per day was significantly lower in HFD  
compared to chow animals (Table 4.1).  However, when expressed as  energy intake (kcal per day),  
HFD had a greater energy intake compared to Chow animals, which explains their greater weight 
gain over the 16 weeks of the study.  There were no differences between exercised and sedentary 
mice in body weight or food intake, and the short (e.g. 5 day) exercise intervention did not result in 
significantly different food intake or weight loss compared to sedentary controls in either diet 
intervention.  
 
Table 4.1: Body weight and food intake for HFD and Chow mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Significant difference, HFD vs. Chow (p<0.05). BW: body weight.  All values are Mean ± SEM. 
  
 HFD Chow p 
BW Baseline (g) 16.7 ± 0.4 17.5 ± 0.5 0.389 
BW Week 16 (g) 30.4 ± 0.7 23.7 ± 0.4 0.000* 
Food Intake (g·day-1) 3.1 ± 0.6 4.0 ± 0.1 0.000* 
Energy Intake (kcal·day-1) 14.7 ± 2.8 12.0 ± 0.3 0.000* 
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4.1.2 Baseline Glucose Tolerance 
 Glucose tolerance testing was performed 1 week prior to the wounding (week 15 of 
feeding) on a subset of HFD-fed (N=10) and chow-fed (N=5) mice.  As expected, HFD-fed mice had 
an impaired response to glucose injection (Figure 4.1A), indicating a higher degree of insulin 
resistance in these mice (diet × time interaction F1.9,24.3=4.794, p=0.019; diet main effect F1,13=8.732, 
p=0.011).  Analysis of area under the glucose response curve (AUC) also indicated that HFD-fed 
mice had impaired glucose tolerance (Figure 4.1B; HFD AUC: 39132 ± 2445; Chow AUC: 28422 ± 
1244; p=0.002).  There were no differences between HFD-Ex and HFD-Sed mice at the 15 week 
baseline GTT measure, thus these groups are pooled for this analysis. 
 
Figure 4.1 Results of baseline glucose tolerance testing in HFD-fed (N=10) and Chow-fed (N=5) mice.  A) Mean glucose 
response curve. * Significantly different HFD vs. Chow at each time point (p<0.05).  B) Mean glucose area under the curve 
from GTT testing. * Significantly different HFD vs. Chow (p=0.002). All values are Mean ± SEM. 
 
 
 
4.2  Wound Healing Kinetics 
4.2.1 Separate Treatment Group Analysis 
 High-fat diet feeding slowed wound healing rate (Figure 4.2A).  When comparing wound 
healing kinetics in sedentary HFD-fed and Chow-fed mice for 10 days post-wounding, there was a 
significant time × diet interaction (F2.9,39.4=3.655, p=0.021) and significant main effects for both diet 
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(F1,13=6.495, p=0.024) and time (F2.9,39.4=59.955, p=0.000).  Post-hoc analysis revealed that Chow-
fed mice had significantly smaller wounds 
starting at day 3 and continuing to day 10 post-
wounding (Figure 4.2A, p<0.05).  We also tested 
whether exercise training could speed healing in 
both Chow-fed and HFD-fed mice.  There was no 
additional effect of exercise on wound healing in 
Chow-fed mice (Figure 4.2B, time × activity 
interaction F3.1,43.1=0.690, p=0.567).  In HFD-fed 
mice, RM-ANOVA indicated a non-significant 
time × activity interaction (Figure 4.2C, 
F3.0,33.4=1.669, p=0.192) but a main effect of 
activity which trended towards significance 
(Figure 4.2C, F1,11=3.267, p=0.098).   
 However, when RM-ANOVA was 
performed only on days 0-5, analysis revealed a 
nearly-significant time × activity interaction 
(Figure 4.2C, F2.2,24.1=3.229, p=0.053) and a 
significant main effect of activity (Figure 4.2C, 
F1,11=4.856, p=.050).  Post-hoc analysis revealed 
significant differences in wound size between  
 
  
Figure 4.2: Wound healing kinetics to 10 days post-wounding.  All wound sizes are expressed as a percentage of baseline 
wound area (day 0).  A) HFD-fed vs. chow-fed mice.  # Significant time × diet interaction (day 0 through day 10, p=0.021). 
* Significant difference in wound size between HFD-fed and chow-fed mice at same day (p<0.05).  HFD: high-fat diet-fed 
mice (N=7). Chow: chow diet-fed mice (N=8).  B) Effect of exercise on healing kinetics in chow-fed mice.  Chow-Ex: 
exercised chow-fed mice (N=8).  Chow-Sed: sedentary chow-fed mice (N=8).  C) Effect of exercise on healing kinetics in 
high-fat diet-fed mice.  # Significant main effect of exercise  (day 0 through day 5, p=0.050). * Significant difference in 
wound size between exercised and sedentary mice at same day (p<0.05).  HFD-Ex: exercised high-fat diet-fed mice (N=6).  
HFD-Sed: sedentary high-fat diet-fed mice (N=7).  All values are mean ± SEM. 
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HFD-Ex and HFD-Sed mice at day 1, day 4, and day 5 post-wounding (Figure 4.2C, p<0.05). 
4.2.2 Pooled Treatment Group Analysis 
 Exercised and sedentary mice in both the chow and HFD groups (HFD-Ex N=6, HFD-Sed 
N=7, Chow-Ex N=8, Chow-Sed N=8) were followed for 10 days post-wounding by photoplanimetry 
to determine the differences in healing rate induced by both exercise and dietary factors (Figure 
4.3A).  There was no time × exercise × diet interaction (F4.0,100.3=0.999, p=0.412).  However, there 
was a significant time × diet interaction (F4.0,100.3=4.976, p=0.001) and a significant main effect of 
diet (F1,25=6.054, p=0.021).  There was no significant time × exercise interaction (F4.0,100.3=1.707, 
p=0.154) nor exercise main effect (F1,25=3.538, p=0.072), although the latter approached 
significance.   
 
Figure 4.3 Comparison of wound healing rate between exercised and sedentary, HFD- and chow-fed mice. A) Kinetic 
analysis of healing rate in the four groups. There was a significant diet × time interaction (p=0.000) and a significant main 
effect of diet (p=0.011) based on repeated-measures ANOVA.  * Post-hoc main effect of exercise at the indicated day 
(p<0.05). † Post-hoc main effect of diet at the indicated day (p<0.05). B) Comparison of time to total closure in the four 
groups. * Significantly higher proportion of HFD-Ex vs. HFD-Sed fully healed (p<0.05).  Total animal numbers: HFD-Ex, 
N=6; HFD-Sed, N=7; Chow-Ex, N=8; Chow-Sed, N=8. All values are mean ± SEM. 
 
 
 
 Although there was not a significant interaction involving exercise, there appeared to be an 
early effect of the exercise training, especially in the HFD groups.  As any exercise main effect or 
interaction was obscured by the similar pattern of healing seen in the Chow-Sed and Chow-Ex 
groups, we did an analysis of effects of diet and exercise early during the healing process.  There 
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was a significant main effect of exercise at day 1 post-wounding (F1,26=5.787, p=0.024).  Post-hoc 
analysis also revealed main effects of diet present at days 3-10 (p<0.05) with the exception of day 4 
at which chow-fed wound areas were not recorded.   
4.2.3 Analysis of Complete Wound Closure 
 After the 10 day period, wounds were followed visually at Days 12, 15, and 20 post-
wounding until complete healing, and between-group differences were assessed by chi-squared 
statistics (Figure 4.3B).  A significantly greater percentage of HFD-Ex had completely healed by 
Day 12 post-wounding compared to HFD-Sed (χ2=6.965, p=0.031).  In addition, a greater 
percentage of HFD-Ex than HFD-Sed mice were fully healed at day 15 post-wounding (83% vs. 43%, 
respectively), although this difference was not significant (χ2=4.729, p=0.094). There were no 
differences in percentage of Chow-Ex and Chow-Sed mice that were fully healed at any day.  At Day 
20 post-wounding, 100% of mice in all groups (Chow and HFD) had fully healed. 
4.2.4 Summary 
 Exercise training sped wound healing rate in obese mice, although the major effect of 
exercise was present early (within 5 days) post-wounding.  This is in line with previous findings in 
aged mice (8) with respect to exercise.  However, in our study, exercise training did not speed 
healing in lean mice compared to sedentary lean controls.  The exercise effect in young lean mice 
has been previously shown to approach significant (8).  However, both mouse strain (C57Bl/6J vs. 
Balb/cByJ) and age (6 months vs. 3 months) differed between our study and the previous study.  
Either or both of these difference may explain the disparate findings, and age and mouse strain 
factors which affect the exercise response need to be more fully elucidated. 
 
4.3 Wound Inflammation 
 A number of papers have shown that wound inflammation in obese mice is associated with 
impaired healing (9, 11-14).  As the inflammatory process happens early (within 5 days) post-
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wounding (6, 16) and as the major effects of exercise appeared to be within this time period in this 
study, we began by analyzing wound tissue inflammation with the hypothesis that exercise would 
reduce wound inflammation in our HFD-fed mice. 
4.3.1 Cytokine Gene Expression 
 Tissue was excised at day 0 (non-wounded skin), day 1, day 3, and day 5 post-wounding for 
analysis of cytokine gene expression.  It was hypothesized that exercise training would reduce 
wound tissue inflammation in obese mice.  However, exercise seemed to have little effect on the 
expression of wound inflammatory markers.  There was no significant day × activity interaction 
(F3,27=0.836, p=0.479) and no significant main effect for either activity (F1,72=0.071, p=0.790) or day 
(F3,72=0.875, p=0.458) for TNF-α (Figure 4.4A).  For IL-1β (Figure 4.4B), there was no significant 
day × activity interaction (F3,70=0.842, p=0.277) and no significant main effect of activity 
(F1,70=0.022, p=0.881).  However, there was a significant main effect of time (F3,70=4.378, p=0.007).  
Post-hoc analysis revealed that IL-1β gene expression was significantly upregulated at day 1 
(p=0.016) and day 3 (p=0.011) post-wounding compared to non-wounded skin expression (Figure 
4.4B).  For anti-inflammatory cytokine IL-10 (Figure 4.4C), there was no significant day × activity  
interaction (F3,72=0.344, p=0.794) and no significant main effect of either activity (F1.72=0.067, 
p=0.797) or day (F3,72=0.770, p=0.514). 
 Cytokine gene expression was taken relative to non-wounded skin expression of the same 
cytokine in chow-fed sedentary mice.  Therefore, we also tested between-group differences in non-
wounded skin comparing HFD-fed animals to chow-fed animals.  A 3×1 ANOVA (Chow-Sed vs. HFD-
Ex vs. HFD-Sed) on skin gene expression of TNF-α revealed no significant between-group 
differences (Figure 4.4A, F2,19=1.488, p=0.251).  Similarly, between-group differences were non-
significant for skin gene expression of IL-1β (Figure 4.4B, F2,19=1.136, p=0.342) and IL-10 (Figure 
4.4C, F2,19=0.844, p=0.446).  However, HFD appeared to upregulate gene expression of all three 
cytokines compared to control animals, so we pooled HFD-fed mice and tested for a main effect of 
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diet (Chow-Sed vs. HFD-Ex + HFD-Sed).  Although no significant diet effects were detected, TNF-α 
was upregulated ~10-fold and approached significance (Figure 4.4A, F1,20=3.049, p=0.096).  IL-1β 
was also upregulated approximately 10-fold; however, the difference between HFD-fed and chow-
fed mice was not as robust for this cytokine (Figure 4.4B, F1,20=2.392, p=0.138).  Finally, IL-10 gene 
expression was only upregulated 2-3 fold in the skin of HFD-fed compared to Chow-fed mice 
(Figure 4.4C, F1,20=1.765, p=0.199). 
 We also tested the effect of exercise on gene expression levels of the cytokine IL-6 similarly 
to that described above.  There was no significant day × activity interaction (F3,63=0.768, p=0.516) 
or significant main effect of activity (F1,63=0.039, p=0.844) for IL-6 (Figure 4.5).  However, there 
was a significant main effect of day (F3,63=8.906, p=0.000) such that wound gene expression of IL-6 
at day1 post-wounding was significantly different than that of non-wounded skin (p=0.000) as well 
as of wounds at day 3 (p=0.005) and day 5 (p=0.037) post-wounding (Figure 4.5).  In non-
wounded skin, a 3×1 ANOVA (Chow-Sed vs. HFD-Ex vs. HFD-Sed) on skin gene expression of IL-6 
revealed no significant between-group differences (Figure 4.5, F2,19=1.145, p=0.339).  Additionally, 
an analysis of the effect of diet did not reach significance (Figure 4.5, F1,20=1.809, p=0.194). 
4.3.2 Cytokine Protein Expression 
 Although gene expression was unaltered by exercise, we hypothesized that post-
transcriptional processes might alter the expression of inflammatory proteins.  Therefore, we 
tested wound protein levels of IL-1β, TNF-α, and IL-10 via ELISA at days 1, 3, and 5 post-wounding.  
Non-wounded skin samples generated insufficient isolated protein for ELISA analysis.  Similar to 
the results of the gene expression assays, exercise training had no effect on protein expression of 
these cytokines.  There was no significant day × activity interaction (F2,58=0.921, p=0.404) and no 
significant main effect for activity (F1,58=0.285, p=0.596) for TNF-α (Figure 4.4D), although there 
was a significant main effect of day (F2,59=15.152, p=0.000).  Post-hoc analysis revealed that TNF-α 
protein expression was significantly upregulated at day 3 (p=0.000)   
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Figure 4.4 Gene and protein expression of cytokines TNF-α, IL-1β, and IL-10 in non-wounded skin and in wound tissue.  
A) Gene expression of TNF-α in non-wounded skin and in wound tissue at day 1, day 3, and day 5 post-wounding. B) Gene 
expression of IL-1β in non-wounded skin and in wound tissue at day 1, day 3, and day 5 post-wounding. * Significant 
difference in gene expression vs. non-wounded skin expression (p<0.05). C) Gene expression of IL-10 in non-wounded 
skin and in wound tissue at day 1, day 3, and day 5 post-wounding. D) Protein expression of TNF-α in wound tissue at day 
1, day 3, and day 5 post-wounding. * Significant difference in protein expression vs. expression at day 1 post-wounding 
(p<0.05). E) Protein expression of IL-1β in wound tissue at day 1, day 3, and day 5 post-wounding. * Significant difference 
in protein expression vs. expression at day 1 post-wounding (p<0.05). F) Protein expression of IL-10 in wound tissue at 
day 1, day 3, and day 5 post-wounding.  Skin: non-wounded skin excised at day 0. Day 1: day 1 post-wounding. Day 3: day 
3 post-wounding. Day 5: day 5 post-wounding.  Total animal numbers: HFD-Ex, Skin N=8, Day 1 N=18, Day 3 N=8, Day 5 
N=7; HFD-Sed, Skin N=7, Day 1 N=17, Day 3 N=8, Day 5 N=7.  Dashed lines in A through C represent gene expression in 
non-wounded skin of chow-fed sedentary mice (N=7) which acted as the referent group (relative gene expression = 1).  
All values are mean ± SEM. 
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and day 5 (p=0.001) compared to expression at day 1 post-wounding (Figure 4.4D).  Likewise, 
there was no significant day × activity 
interaction (F2,56=0.060, p=0.942) and no 
significant main effect of activity (F1,56=0.379, 
p=0.540) for IL-1β (Figure 4.4E), although 
again there was a significant main effect of day 
(F2,56=9.021, p=0.000).  Post-hoc analysis 
revealed that IL-1β wound protein expression 
was significantly down-regulated at day 3 
(p=0.029) and day 5 (p=0.001) compared to 
expression at day 1 post-wounding (Figure 
4.4E).  Finally, there was no significant day × 
activity interaction (F2,55=0.304, p=0.739) and no significant main effect of either activity 
(F1,55=0.329, p=0.568) or day (F2,55=0.150, p=0.861) for IL-10 (Figure 4.4F). 
4.3.3 Chemokine Gene Expression 
 As with the cytokines described above, we tested gene expression of chemokines MCP-1 (a 
macrophage chemoattractant) and KC (a neutrophil chemoattractant).  We hypothesized that 
exercise training would reduce wound site chemokine gene expression in HFD-fed mice.  However, 
for MCP-1 (Figure 4.6A) there was no significant day × activity interaction (F3,70=0.395, p=0.757) 
and no significant main effect of activity (F1,70=0.005, p=0.944).  There was a significant main effect 
of day (F3,70=13.515, p=0.000).  Post-hoc analysis revealed that MCP-1 gene expression in wounds 
at day 1 post-wounding was significantly higher than in non-wounded skin or in wounds at day 3 or 
day 5 post-wounding (Figure 4.6A, p=0.000 for all comparisons).  For KC (Figure 4.6B), there was 
no significant day × activity interaction (F3,72=0.371, p=0.774) and no significant main effect of 
activity (F1,72=0.721, p=0.402).  Again, there was a significant main effect of day in which KC gene 
Figure 4.5 Gene expression of cytokine IL-6 in non-
wounded skin and in wound tissue. * Significant 
difference in gene expression versus all other time 
points. Skin: non-wounded skin excised at day 0. Day 1: 
day 1 post-wounding. Day 3: day 3 post-wounding. Day 
5: day 5 post-wounding.  Total animal numbers: HFD-Ex, 
Skin N=8, Day 1 N=18, Day 3 N=8, Day 5 N=7; HFD-Sed, 
Skin N=7, Day 1 N=17, Day 3 N=8, Day 5 N=7.  Dashed 
line represents gene expression in non-wounded skin of 
chow-fed sedentary mice (N=7) which acted as the 
referent group (relative gene expression = 1).  All values 
are mean ± SEM. 
64 
 
expression was significantly greater at day 1 post-wounding compared to non-wounded skin 
(p=0.000) or in wounds at day 3 (p=0.003) or day 5 (p=0.002) post-wounding (Figure 4.6B). 
 In non-wounded skin, a 3×1 ANOVA (Chow-Sed vs. HFD-Ex vs. HFD-Sed) on skin gene 
expression of MCP-1 revealed no significant between-group differences (Figure 4.6A, F2,19=1.041, 
p=0.372).  Additionally, an analysis of the effect of diet did not reach significance (Figure 4.6A, 
F1,20=2.176, p=0.156).  Similarly, for KC, non-wounded skin gene expression analysis revealed no 
significant between=group differences (Figure 4.6B, F2,19=0.940, p=0.408) and no significant effect 
of diet (Figure 4.6B, F1,20=1.493, p=0.236).  However, although non-significant, both MCP-1 and KC 
were upregulated approximately 5-fold in non-wounded skin of HFD-fed mice compared to their 
Chow-fed counterparts. 
 
Figure 4.6 Gene expression of chemokines MCP-1 and KC in non-wounded skin and in wound tissue. A) Gene expression 
of MCP-1 in non-wounded skin and in wound tissue at day 1, day 3, and day 5 post-wounding. * Significant difference in 
gene expression at day 1 post-wounding compared to all other time points (p<0.05).  B) Gene expression of KC in non-
wounded skin and in wound tissue at day 1 post-wounding. * Significant difference in gene expression at day 1 post-
wounding compared to expression at all other time points (p=0.000).  Skin: non-wounded skin excised at day 0. Day 1: 
day 1 post-wounding. Day 3: day 3 post-wounding. Day 5: day 5 post-wounding.  Total animal numbers: HFD-Ex, Skin 
N=8, Day 1 N=18, Day 3 N=8, Day 5 N=7; HFD-Sed, Skin N=7, Day 1 N=17, Day 3 N=8, Day 5 N=7.  Dashed lines represent 
gene expression in non-wounded skin of chow-fed sedentary mice (N=7) which acted as the referent group (relative gene 
expression = 1).  All values are mean ± SEM. 
 
4.3.4 Summary 
 Contrary to previous findings in aged mice (8), exercise training seemingly does not affect 
wound site inflammation in obese mice, either as measured by gene expression or wound protein 
expression analysis of a variety of pro- and anti-inflammatory cytokines and chemokines.  This 
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suggests a mechanism other than inflammatory changes may be responsible for the observed 
exercise effect on healing kinetics, despite the fact that the major effect of exercise occurs within the 
normal period of inflammation during the wound healing process (i.e. within ~5 days post-
wounding).  Thus, we tested several other potential mechanisms as described in the following 
sections. 
 
4.4 Wound Growth Factor Expression 
4.4.1 Gene Expression 
 Due to the lack of an association between quickened wound healing and altered wound 
inflammation in the obese mice, we also tested the exercise effect on gene expression of several 
growth factors important in the regulation of wound healing.  For angiogenesis inducer VEGF 
(Figure 4.7A), there was an activity × day interaction which approached significance (F3,72=2.263, 
p=0.088).  Similarly, the main effect of activity approached significance (F1,72=2.789, p=0.099).  
There was a significant main effect of day (F3,72=8.753, p=0.000) such that VEGF gene expression in 
the non-wounded skin was significantly greater than expression at day 1 (p=0.000), day 3 
(p=0.002), or day 5 (p=0.001) post-wounding (Figure 4.7A).  In non-wounded skin, 3×1 ANOVA 
(Chow-Sed vs. HFD-Ex vs. HFD-Sed) revealed no significant differences between groups 
(F2,19=1.817, p=0.190) and no significant effect of diet (F1,20=1.322, p=0.264). 
 Gene expression analysis of PDGF (Figure 4.7B) revealed a significant day × activity 
interaction (F3,72=3.109, p=0.032) and a main effect of activity that approached significance 
(F1,72=3.571, p=0.063).  There was a significant main effect of day (F3,72=14.106, p=0.000) such that 
gene expression of PDGF in non-wounded skin was significantly greater than that in wound tissue 
at day 1, day 3, or day 5 post-wounding (p=0.000 for all time points).  In non-wounded skin, 3×1 
ANOVA (Chow-Sed vs. HFD-Ex vs. HFD-Sed) approached significance (F2,19=2.942, p=0.077) with no 
significant effect of diet (F1,20=2.564, p=0.125). 
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 Analysis of the gene expression of TGF-β (Figure 4.7C) revealed no significant day × activity 
interaction (F3,68=0.078, p=0.971) and no significant main effect of activity (F1,68=0.003, p=0.959).  
The main effect of day was significant (F3,68=3.318, p=0.025) such that gene expression at day 3 
post-wounding different than that only at day 1 post-wounding (p=0.018).  In non-wounded skin, 
there were no significant between-group differences (F2,17=0.424, p=0.661) and there was no 
significant effect of diet (F1,18=0.882, p=0.377). 
 
Figure 4.7 Gene expression of selected growth factors in non-wounded skin and in wound tissue.  A) Gene expression of 
VEGF in non-wounded skin and in wound tissue at day 1, day 3, and day 5 post-wounding. * Significant difference in gene 
expression in normal skin compared to wound tissue at all time points (p<0.05).  B) Gene expression of PDGF in non-
wounded skin and in wound tissue at day 1, day 3, and day 5 post-wounding. * Significant difference in gene expression in 
normal skin compared to wound tissue at all time points (p<0.05).  C) Gene expression of TGF-β in non-wounded skin and 
in wound tissue at day 1, day 3, and day 5 post-wounding. * Significant difference in gene expression in wounds at day 3 
compared to expression in wound tissue at day 1 post-wounding (p=0.001).  D) Gene expression of HIF1α in non-
wounded skin and in wound tissue at day 1, day 3, and day 5 post-wounding. * Significant difference in gene expression in 
normal skin compared to wound tissue at day 1 post-wounding (p=0.018).  Skin: non-wounded skin excised at day 0. Day 
1: day 1 post-wounding. Day 3: day 3 post-wounding. Day 5: day 5 post-wounding.  Total animal numbers: HFD-Ex, Skin 
N=8, Day 1 N=18, Day 3 N=8, Day 5 N=7; HFD-Sed, Skin N=7, Day 1 N=17, Day 3 N=8, Day 5 N=7.  Dashed lines represent 
gene expression in non-wounded skin of chow-fed sedentary mice (N=7) which acted as the referent group (relative gene 
expression = 1).  All values are mean ± SEM. 
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 Finally, for tissue hypoxia marker HIF1α (Figure 4.7D), there was no significant day × 
activity interaction (F3,72=0.634, p=0.595) and no significant main effect of activity (F1,72=1.191, 
p=0.279).  There was a significant main effect of day (F3,72=5.328, p=0.002) such that the expression 
of HIF1α at day 1 post-wounding was significantly less than that in non-wounded skin (p=0.001).  
In non-wounded skin, there were no between-group differences (F2,19=1.070, p=0.363) and no 
significant effect of diet (F1,20=1.568, p=0.225). 
4.4.2 Summary 
 Consistent with our inflammation data, we were unable to discern any significant effect of 
exercise on the gene expression of several growth factors.  Interestingly, we found reductions in 
wound expression of growth factors VEGF and PDGF at day 1, day 3, and day 5 post-wounding 
compared to the expression level in the non-wounded skin.  This was unexpected as previous data 
suggests that application of a wound should stimulate production and release of the growth factors 
tested (5, 6) rather than suppress gene expression as we observed.  This finding warrants further 
investigation. 
 
4.5 Wound Macrophages 
4.5.1 Gene Expression 
 In addition to the secreted factors (cytokines, chemokines, growth factors) discussed above, 
we also analyzed gene expression of several cell surface and secreted factors as markers of 
macrophage number and phenotype.  For macrophage number, we analyzed gene expression of 
F4/80, a macrophage-specific cell surface protein (10).  For determination of macrophage 
phenotype, we analyzed expression of FIZZ1 and CD206 as measures of alternative macrophage 
activation (4).  We also measured TLR4 gene expression as exercise training has been previously 
shown to reduce TLR4 expression concomitantly with a reduction in inflammation (3).   
68 
 
 For macrophage marker F4/80 (Figure 4.8A), there was no significant day × activity 
interaction (F3,72=2.152, p=0.101) and no significant main effect of activity (F1,72=1.012, p=0.318).  
However, there was a significant main effect of day (F3,72=7.609, p=0.000).  Post-hoc analysis 
indicated that F4/80 gene expression was significantly reduced at day 1 post-wounding compared 
to expression in non-wounded skin (p=0.000) and in wounds at day 3 (p=0.000) and day 5 
(p=0.000) post-wounding (Figure 4.8A).  For TLR4 (Figure 4.8B), there was no significant day × 
activity interaction (F3,72=0.448, p=0.719) and no significant main effect of either activity 
(F1,72=0.002, p=0.965) or day (F3,72=1.203, p=0.315). 
 
Figure 4.8 Gene expression of macrophage cell surface markers in non-wounded skin and in wound tissue.  A) Gene 
expression of F4/80 in non-wounded skin and in wound tissue at day 1, day 3, and day 5 post-wounding. * Significant 
difference in gene expression at day 1 post-wounding compared to expression at all other time points (p<0.05).  B) Gene 
expression of TLR4 in non-wounded skin and in wound tissue at day 1, day 3, and day 5 post-wounding.  Skin: non-
wounded skin excised at day 0. Day 1: day 1 post-wounding. Day 3: day 3 post-wounding. Day 5: day 5 post-wounding.  
Total animal numbers: HFD-Ex, Skin N=8, Day 1 N=18, Day 3 N=8, Day 5 N=7; HFD-Sed, Skin N=7, Day 1 N=17, Day 3 N=8, 
Day 5 N=7.  Dashed lines represent gene expression in non-wounded skin of chow-fed sedentary mice (N=7) which acted 
as the referent group (relative gene expression = 1).  All values are mean ± SEM. 
 
 In non-wounded skin, a 3×1 ANOVA (Chow-Sed vs. HFD-Ex vs. HFD-Sed) on skin gene 
expression of F4/80 (Figure 4.8A) revealed a nearly significant effect between-groups (F2,19=3.156, 
p=0.066).  Additionally, an analysis of the effect of diet revealed an effect that approached 
significance (F1,20=2.985, p=0.099).  Although significance was not achieved, exercise appeared to 
partially ameliorate the HFD-induced upregulation of F4/80 gene expression in non-wounded skin 
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(Figure 4.8A).  For TLR4 gene expression (Figure 4.8B), there was no between-group difference 
(F2,19=0.537, p=0.593) and no significant effect of diet (F1,20=0.191, p=0.667) in non-wounded skin.  
 In addition to the above markers, we also tested for the exercise effect on gene expression 
of selected markers of alternative macrophage activation.  For CD206 (Figure 4.9A), the 
macrophage mannose receptor, there was no significant day × activity interaction (F3,68=0.050, 
p=0.985) and no significant main effects of either activity (F1,68=0.503, p=0.481) or day (F3,68=2.136, 
p=0.104).  For the secreted product FIZZ1 (Figure 4.9B), there was no significant day × activity 
interaction (F3,68=0.062, p=0.979) and no significant main effect of activity (F1,68=0.140, p=0.710).  
However, there was a significant main effect of day (F3,68=66.070, p=0.000) such that the gene 
expression of FIZZ1 in non-wounded skin was significantly greater than in wound tissue at day 1, 
day 3, and day 5 post-wounding (p=0.000 for all time points).   
 
Figure 4.9 Gene expression of markers of alternative macrophage activation in non-wounded skin and in wound tissue.  
A) Gene expression of CD206 (mannose receptor) in non-wounded skin and in wound tissue at day 1, day 3, and day 5 
post-wounding.  B) Gene expression of FIZZ1 in non-wounded skin and in wound tissue at day 1, day 3, and day 5 post-
wounding. * Significant difference in gene expression in non-wounded skin compared to expression in wound tissue at all 
other time points (p=0.000 for all time points). † Significant difference in gene expression of Chow-Sed compared to HFD-
Ex (p=0.037) and HFD-Sed (p=0.043) in non-wounded skin.  Skin: non-wounded skin excised at day 0. Day 1: day 1 post-
wounding. Day 3: day 3 post-wounding. Day 5: day 5 post-wounding.  Total animal numbers: HFD-Ex, Skin N=8, Day 1 
N=18, Day 3 N=8, Day 5 N=7; HFD-Sed, Skin N=7, Day 1 N=17, Day 3 N=8, Day 5 N=7.  Dashed lines represent gene 
expression in non-wounded skin of chow-fed sedentary mice (N=7) which acted as the referent group (relative gene 
expression = 1).  All values are mean ± SEM. 
 
 
 Analysis of CD206 gene expression in non-wounded skin (Figure 4.9A) revealed no 
differences between groups (F2,17=1.269, p=0.306) and no significant effect of diet (F1,18=2.105, 
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p=0.164).  However, for FIZZ1 (Figure 4.9B) the between-group ANOVA was significant 
(F2,19=4.888, p=0.021), and there was also a significant effect of diet (F1,19=10.256, p=0.005).  Post-
hoc analysis revealed that LFD-Sed mice had significantly reduced gene expression of FIZZ1 
compared to HFD-Ex (p=0.037) as well as HFD-Sed (p=0.043) mice in non-wounded skin (Figure 
4.9B).  There was no statistical difference in gene expression of FIZZ1 between HFD-Ex and HFD-
Sed mice in non-wounded skin (p=0.969). 
4.5.2 Immunofluorescence Microscopy 
 In order to further test the finding that exercise (non-significantly) reduced gene expression 
of F4/80 in non-wounded skin of HFD-fed mice, we sectioned frozen non-wounded skin samples 
from HFD-Ex and HFD-Sed mice and stained for the macrophage marker CD68.  The complete 
staining protocols can be found in Appendix B.  Antibody dilutions were 1:500 for both primary 
and secondary antibodies, and images were taken at 20X and quantified as the average CD68+ cell 
number in 1-3 high-power fields.  Although HFD-Ex mice had fewer CD68+ cells per field than their 
HFD-Sed counterparts (Figure 4.10), the difference was not significant (p=0.242).    Representative 
micrographs are shown in Figure 4.10B and Figure 4.10C. 
4.5.3 Summary 
 Exercise appeared to have little effect on either macrophage number or phenotype as 
measured by gene expression of selected markers.  The most promising finding was a potential 
exercise-related decrease in F4/80 gene expression in the skin of obese mice, although the 
difference was not significant.  This warranted further investigation.  Therefore, a subset of non-
wounded skin samples were sectioned and stained for the macrophage marker CD68 and 
quantified for macrophage number.  Although HFD-Ex mice had numerically fewer macrophages 
per high-power field (8.4±2.1 vs. 11.8±1.8 in HFD-Sed), the difference was non-significant 
(p=0.242).  As this technique is only semi-quantitative, and because the sample numbers were low 
(N=5 HFD-Ex, N=8 HFD-Sed), further work in this area is necessary to determine if the potential 
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changes in non-wounded skin macrophage number with exercise are involved in the quickened 
wound healing seen in obese exercised mice. 
 
 
 
Figure 4.10 Immunofluorescence microscopy analysis of non-wounded skin macrophage number. A) Number of CD68+ 
cells per 20X high-power field.  B) Representative micrograph of non-wounded skin in a HFD-Ex mouse.  C) 
Representative micrograph of non-wounded skin in a HFD-Sed mouse.  Green: CD68.  Blue: DAPI (nucleus).  HFD-Ex, N=5; 
HFD-Sed, N=8.  All values are mean ± SEM. 
 
 
4.6 Training Effect on Glucose Tolerance 
 We also determined the effect of exercise training on glucose tolerance as elevated blood 
glucose has previously been shown to be associated with poor healing (6).  On a subset of mice 
(N=5 HFD-Ex; N=5 HFD-Sed), GTT was measured at day 1 post-wounding in addition to baseline 
(Figure 4.11A).  Although HFD-Ex had slightly higher glucose intolerance at baseline (prior to 
exercise), there was no significant interaction (activity × time point F1,8=0.160, p=0.699) nor were 
there significant time point (baseline vs. day 1, F1,8=3.072, p=0.188) or activity (HFD-Ex vs. HFD-
Sed, F1,8=2.971, p=0.123) main effects, indicating that the exercise intervention had little effect on 
insulin resistance.  We also measured fasting plasma glucose levels at both time points (Figure 
4.11B).  There was a significant activity × time point interaction (F1,8=6.098, p=0.039) and a 
B 
C 
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significant main effect of day (F1,8=6.390, p=0.035).  There was no significant main effect of activity 
(F1,8=1.540, p=0.250).  Post-hoc analysis revealed that the interaction was driven by elevated 
fasting glucose in HFD-Ex compare to HFD-Sed at baseline, a result that is likely spurious given that 
the treatments did not differ between groups prior to this time point.  At day 1 post-wounding, 
fasting glucose levels were reduced in the HFD-Ex group to the same as that of the HFD-Sed group.  
Whether this finding is an effect of the exercise intervention or simply represents a normalization 
of fasting glucose in HFD-Ex warrants further investigation. 
 
 
Figure 4.11 Glucose tolerance responses to 4 days of exercise training. A) Glucose AUC response to exercise training.  B) 
Fasting blood glucose response to exercise training.  * Significant difference in glucose of HFD-Ex vs. HFD-Sed mice at the 
indicated time (p<0.05).  HFD-Ex, N=5; HFD-Sed, N=5.  Baseline is 1 week prior to onset of exercise (day -10).  Day 1 is one 
day post-wounding (5 days after onset of exercise).  All values are mean ± SEM. 
 
4.7 Wound Healing in Lean Mice 
 In addition to testing the effect of exercise on wound healing in obese mice, we also tested 
whether the same exercise paradigm could speed healing in young (6-8 week old) lean mice.  
Previous research in Balb/cByJ mice demonstrated that the effect of exercise tended to speed 
healing in young lean mice, although the effect was not significant (8).  We tested this in C57Bl/6J 
mice to determine if young lean mice could be used as a proxy for the study of the exercise effect on 
wound healing.  Research with these mice is significantly cheaper and less time-consuming, so the 
ability to use these mice would represent a major advantage to researchers. 
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 Due to the well-known effect of estrogen on wound healing (2, 6), we also sought to 
determine the role of sex in the wound healing response to exercise in young lean mice.  Therefore, 
we compared exercise and sedentary, young lean male and female C57Bl/6J mice (N=10-16/group).  
Wound healing kinetics and time to complete healing was assessed as described for the obese mice 
above.  Wound size differences were analyzed only at day 1, day 5, and day 10 post-wounding. 
 Kinetic analysis of wound healing by RM-ANOVA (Figure 4.12A) revealed no significant 
time × sex × activity interaction (F2.1,99.8=0.623, p=0.544) and no significant time × activity 
interaction (F2.1,99.8=0.690, p=0.510).  However, there was a significant day × sex interaction 
(F2.1,99.8=25.827, p=0.000).  The main effects of time (F2.1,99.8=792.640, p=0.000) and sex 
(F1,48=58.347, p=0.000) were significant, while the main effect of activity (F1,48=0.378, p=0.542) was 
not significant.  Post-hoc analysis revealed that female mice had significantly smaller wounds than 
their male counterparts at day 1 (p=0.000) and day 5 (p=0.000) post-wounding (Figure 4.12A). 
 
 Figure 4.12 Effect of exercise and sex on wound healing in young (6-8 week old) lean C57Bl/6J mice. A) Wound sizes in 
male and female, exercised and sedentary mice at days 1, 5, and 10 post-wounding.  Areas are expressed as a percentage 
of wound area at baseline (day 0). * Significant difference, female vs. male, at indicated day (p<0.05).  B) Percentage of 
mice fully healed in each group, at each day post-wounding.  There was a significant effect of sex (p=0.017) such that 
female mice healed more quickly than male mice.  Ex, exercised; Sed, sedentary; F, female (N=16 Ex, N=16 Sed); M, male 
(N=10 Ex, N=10 Sed).  All values are mean ± SEM. 
 
 
 Time to total wound closure was analyzed across the four groups (female-exercised, female-
sedentary, male-exercised, male-sedentary) by Kruskal-Wallis independent samples ANOVA 
(Figure 4.12B).  The overall ANOVA was not significant (p=0.107).  However, Mann-Whitney U 
tests for main effects revealed a significant effect of sex (p=0.017) in which female mice had a 
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reduced median time to closure compared to male mice (11 vs. 12 days, respectively).  The effect of 
exercise was not significant (p=0.873).  Given these data, it appears that exercise is not efficacious 
in speeding healing in these young lean mice, similar to our findings in older lean mice (Figure 
4.2B).  However, female mice healed faster than their male counterparts.  As we have used only 
female mice in our obesity and previous aging studies, this suggests that male mice in these 
populations may have different responses to exercise, a hypothesis that warrants future 
investigation. 
 
4.8 Adipose Tissue Inflammation 
 Finally, we tested the effect of the outlined short-term exercise bout on adipose tissue gene 
expression of selected inflammatory markers in mice euthanized at day 1 post-wounding (5th day 
of exercise).  Previous research from our lab (15) and others (1, 7) has demonstrated that exercise 
training can reduce adipose tissue inflammation in obese animals.  Thus, we hypothesized that an 
exercise-induced reduction in adipose tissue inflammation, either in visceral adipose or in 
subcutaneous adipose tissue near the wound area, may be associated with improvements in 
healing. 
4.8.1 Cytokine Gene Expression 
 We tested gene expression of several cytokines in both subcutaneous and epididymal 
adipose tissue (Figure 4.13B) in exercised and sedentary HFD-fed mice at day 1 post-wounding.  In 
subcutaneous adipose tissue (Figure 4.13A), there were no differences in gene expression of IL-1β 
(p=0.126), IL-6 (p=0.154), IL-10 (p=0.425), or TNF-α (p=0.373), although exercise appeared to 
upregulate the expression of each, with >2-fold increases in expression in both IL-1β and TNF-α.  In 
epididymal adipose tissue (Figure 4.13B), there was no significant difference in gene expression of 
IL-10 (p=0.460).  However, there was a near significant exercise-related increase in IL-6 expression 
(p=0.077) and significant increases with exercise in IL-1β (p=0.005) and TNF-α (p=0.046). 
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Figure 4.13 Gene expression of selected cytokines in adipose tissue of mice euthanized at day 1 post-wounding.  A) Gene 
expression in subcutaneous adipose tissue.  B) Gene expression in epididymal adipose tissue. * Significant difference, 
HFD-Ex vs. HFD-Sed.  Subcutaneous: HFD-Ex N=9, HFD-Sed N=7.  Epididymal: HFD-Ex N=10, HFD-Sed N=10.  HFD-Sed 
expression for each gene acted as the referent group.  All values are mean ± SEM. 
 
4.8.2 Cell Surface Marker Gene Expression 
 In addition to the cytokines above, we also tested for an exercise effect on gene expression 
of macrophage marker F4/80 in subcutaneous and epididymal adipose tissue at day 1 post-
wounding (Figure 4.14).  There was no 
significant difference in expression of F4/80 
in subcutaneous adipose tissue (p=0.564).  In 
epididymal adipose tissue, the difference 
approached significance (p=0.051).  
Additionally, there appeared to be differential 
regulation of F4/80 expression by exercise in 
adipose as F4/80 expression in subcutaneous 
adipose tissue of exercised mice was 84% that 
of sedentary controls, while in epididymal adipose tissue exercise induced a nearly 2.5-fold 
increase.  The amount of adipose tissue collected from both depots was insufficient to allow for 
follow-up of this data with protein expression or immunohistochemistry analyses.  Thus, future 
research is necessary to support these preliminary findings with more concrete data. 
Figure 4.14 Gene expression of macrophage marker 
F4/80 in adipose tissue of mice euthanized at day 1 post-
wounding. Subcutaneous: HFD-Ex N=9, HFD-Sed N=7.  
Epididymal: HFD-Ex N=10, HFD-Sed N=10.  HFD-Sed 
expression for each gene acted as the referent group.  All 
values are mean ± SEM. 
76 
 
4.8.3 Summary 
 Exercise appears to have an unexpected effect on adipose tissue inflammation in our mice.  
At day 1 post-wounding, exercise was associated with increased gene expression of IL-1β and TNF-
α in epididymal adipose tissue.  Additionally, there were near-significant increases in IL-6 and 
F4/80 in the same adipose depot.  The effect in subcutaneous adipose tissue was less robust; 
however, exercise did tend to non-significantly increase gene expression of inflammatory cytokines 
IL-1β, IL-6, and TNF-α in this depot as well.  Interestingly, F4/80 expression was slightly reduced in 
subcutaneous adipose tissue, suggesting that exercise may differentially regulate macrophages in 
different adipose tissue depots.   
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CHAPTER 5 
SUMMARY AND DISCUSSION 
 
5.1 Discussion 
5.1.1 Wound Healing Kinetics 
 The major finding of this study was that short-term treadmill exercise (3 days prior-to and 
5 days after wounding) speeds wound healing rate in obese, high-fat diet-fed female mice.  This is in 
line with previous studies in aged mice (16) and older adults (4), but to the best of our knowledge 
this is the first report of an exercise effect on cutaneous wound healing using an obesity model.  
Obesity is known to impede wound healing (35), and this has been demonstrated in animal models 
of obesity (27).   
 The major effect of exercise appeared to be early during wound healing.  Interestingly, 
analysis of healing over the entire 10 day period resulted in a non-significant main effect of 
exercise.  However, limiting the analysis to the first 5 days post-wounding resulted in a significant 
effect of exercise wherein exercised obese mice healed more quickly than sedentary obese mice.  
We found no differences in healing kinetics in lean mice of the same age.  It also appeared that the 
exercise intervention in obese mice sped healing to the point that it was no different than the 
healing response in lean mice.  As HFD feeding did slow healing in our study similar to that seen in 
previous studies, this suggests that our exercise intervention may normalize healing in these obese 
mice. 
 Of potential interest is the differential impact of exercise prior to and during wound healing.  
Mice in this study exercised for 3 days prior to wounding and for 5 days post-wounding.  It is not 
known whether exercise alone either prior to wounding or during wounding could show similar 
effects.  The exercise intervention as it currently stands could be useful as a therapy for patients 
scheduled to undergo bariatric surgery as the application of the wound is predictable in these 
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instances.  However, if exercise only after the wound is applied is efficacious in speeding healing, 
this paradigm could be applied to any instance in which an obese individual is wounded.  Further 
study in this area would be of great interest as such results could be applied clinically in the event 
of unexpected wounding. 
 The exercise intervention was ended at day 5 post-wounding in this study.  This was done 
to remain consistent with previous studies using exercise in aged mice (16) and restraint stress in 
mice (24).  As noted above, the effect of exercise on healing rate was limited to the first 5 days post-
wounding, the same period during which the exercise intervention was actually in place.  Future 
studies in which the exercise intervention is continued to 10 days post-wounding may result in 
significant main effects of exercise over the entire 10 day period.   
 Although exercise training did not speed healing rate in lean mice, an analysis of the effect 
of exercise across both HFD- and Chow-fed mice showed that exercise significantly reduced wound 
size at day 1 post-wounding compared to sedentary mice regardless of diet intervention.  This 
finding was driven mostly by the effect of exercise on HFD-fed mice (~50% closure at day 1 in HFD-
Ex compared to 20% closure in HFD-Sed mice).  However, there was also a mild effect of exercise in 
Chow-fed mice at this time point as well (~40% closure in Chow-Ex compared to 25% closure in 
Chow-Sed).  This suggests that exercise is acting very early in the wound healing process to 
influence healing speed.  As changes in inflammation seem to be unrelated to wound healing rate, 
other early factors such as hemostasis and wound contraction may play a role.  These possibilities 
are discussed in more detail in section 5.1.8. 
 Time to total wound closure was also relatively quickened in HFD-Ex mice compared to 
HFD-Sed.  At day 12 post-wounding, two-thirds of HFD-Ex had fully healed compared to none in the 
HFD-Sed mice.  This trend continued to day 15, although the difference here was non-significant 
due to the relatively low number of mice used in this portion of the study.  Although the effects of 
exercise on both healing rate and time-to-closure were somewhat moderate, they could have 
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important clinical consequences.  Reduced wound size and faster healing may help prevent, or at 
least limit the risk of, wound site infections or other complications. 
5.1.2 Wound Inflammation 
 As the effect of exercise was seemingly limited to early (day 0 to day 5) post-wounding, we 
hypothesized that exercise would reduce wound inflammation, which has been previously shown to 
be excessive in obese mice (5, 8, 26, 34) and has been shown to be ameliorated by exercise in aged 
mice (16).  Surprisingly, unlike the previous study in aged mice (16), exercise seemed not to affect 
wound site gene or protein expression of inflammatory cytokines TNF-α, IL-6, and IL-1β, or of anti-
inflammatory cytokine IL-10.  This is to our knowledge the first report of an exercise effect on 
wound healing which is unrelated to alterations in wound site inflammation.   
 As expected, the wounding procedure resulted in a large increase in gene and protein 
expression of inflammatory cytokines at day 1 post-wounding when compared to expression in the 
skin.  IL-1β gene expression was increased 10-fold in day 1, day 3, and day 5 wounds compared to 
skin expression in HFD-fed mice.  IL-1β and IL-6 also appeared to precede TNF-α in the wounds, as 
the peak IL-1β protein response and IL-6 gene expression response were at day 1 post-wounding, 
the same time point in which TNF-α protein expression was lowest.  IL-10 was not altered across 
time either in gene or protein expression, and skin levels did not differ from wound levels at any 
time point measured.  It is possible that IL-10 differences may only be detectable later in the wound 
healing process, as inflammation subsides to allow tissue remodeling to occur at later time points 
(36).   
 Gene expression of macrophage chemokine MCP-1 and neutrophil chemokine KC were also 
measured.  Interestingly, MCP-1 gene expression peaked at day 1 post-wounding and had returned 
to expression levels similar to that in non-wounded skin by day 3 post-wounding.  Conversely, KC 
gene expression peaked at day 1 post-wounding (100-fold higher than in non-wounded skin) but 
remained non-significantly elevated at day 3 and day 5 post-wounding (~10-20 fold higher at each 
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time point).  This suggests that, potentially, neutrophil chemotaxis in obese mice may continue 
beyond the usual 24-48h post-wounding seen in lean mice (36).  This may be one of the 
mechanisms by which obesity slows healing in our mouse model. 
 In addition to the kinetic responses of the listed cytokines and chemokines, we were also 
interested in non-wounded skin expression of these factors.  While the amount of protein extracted 
from the non-wounded skin was insufficient for ELISA analyses, sufficient mRNA was extracted 
from these samples for RT-PCR analysis.  In general, HFD-feeding caused an increase in pro-
inflammatory cytokine and chemokine gene expression of 4-10 fold (IL-6, 4-fold; IL-1β, 10-fold; 
TNF-α, 10-fold; MCP-1, 5-fold; KC, 5-fold).  However, due to large variability in non-wounded skin 
expression levels, none of these values were significantly different than those of Chow-fed mice, 
although the 10-fold upregulation in TNF-α approached significance (p<0.10).  Future work in this 
area should attempt to support these findings with protein analysis.  Inflammatory differences in 
non-wounded skin may play a major role in the progression of healing post-wounding, thus this 
area is an important avenue for future research.  
5.1.3 Wound Growth Factors 
 In addition to the inflammatory mediators mentioned above, we were also interested in the 
role of various growth factors on the healing process, and the kinetic response of these growth 
factors to the exercise intervention.  Many of these factors, including angiogenesis initiator VEGF as 
well as TGF-β, also play a role in suppressing inflammation due to their release from alternatively 
activated macrophages (18).  We additionally considered the role of exercise-induced wound 
hypoxia as a potential mechanism for promoting angiogenesis and tissue repair, thus we measured 
gene expression of hypoxia-associated factors including VEGF and HIF1α.   
 Interestingly, we found a reduced expression of nearly all tested growth factors in the 
wounds compared to non-wounded skin in HFD-fed mice, although these differences were not 
always significant.  Both VEGF and PDGF expression were reduced in day 1, day 3, and day 5 
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wounds compared to non-wounded skin.  TGF-β expression did not differ in day 1 wounds 
compared to non-wounded skin, but was reduced in day 3 wounds and had returned to baseline by 
day 5.  HIF1α was reduced at day 1 compared to non-wounded skin and returned to baseline by day 
3 post-wounding.   
 The significance of these findings are currently difficult to explain.  As previously stated, 
several of these factors play a role in suppressing inflammation.  Thus, expression of these factors 
may be downregulated during the early wound healing response to allow inflammation to progress 
unabated.  There may be alternative explanations for these findings, and further research in this 
area should support these gene expression data with protein analysis.  These findings should also 
be extended to other growth factors which play important roles in healing, including IGF-1 and 
fibroblast growth factor (FGF) among others. 
 There were small but non-significant upregulations in gene expression of VEGF, PDGF, and 
HIF1α in non-wounded skin of HFD- compared to Chow-fed controls.  HFD-fed mice had 2-6 fold 
increases in gene expression of these factors in non-wounded skin compared to Chow-fed mice.  In 
TGF-β, HFD-fed mice had approximately a 1.5-fold reduction in expression compared to Chow.  
These data suggest that there are few differences in gene expression of the selected growth factors 
in non-wounded skin between Chow-fed and HFD-fed mice. 
5.1.4 Wound Macrophages 
 Perhaps the most interesting finding to come from the mechanistic portion of this study is 
the role of diet and exercise on macrophage number in non-wounded skin and in wound tissue.  An 
initial analysis of F4/80 gene expression as a crude marker for macrophage number in the skin and 
wounds of these mice revealed a day × activity interaction that was not significant but nevertheless 
was strong enough (p=0.101) to be of interest.  As the main effect of day was significant, post-hoc 
analysis showed that F4/80 gene expression in day 1 wounds was significantly lower than at all 
other time points.  This was not particularly surprising as macrophage infiltration into the wound 
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site generally occurs somewhat later than the first day post-wounding (36).  As the interaction was 
not statistically significant, no other post-hoc tests were permissible.  An analysis between-groups 
in the non-wounded skin demonstrated that there were nearly-significant differences in F4/80 
gene expression between groups, with HFD-Sed expression ~2-fold higher than that of Chow-Sed.  
Exercise appeared to partially restore the HFD-fed expression to that of Chow-Sed, with HFD-Ex 
expression only ~1.3-fold higher than Chow-Sed.   
 The kinetic response of F4/80 gene expression also appeared to differ between HFD-Ex and 
HFD-Sed.  Because the interaction term and the main effect of exercise were both non-significant in 
this study, we were unable to perform 
post-hoc tests for between-group 
differences at individual time points.  
However, HFD-Ex seemed to have a quicker 
induction of F4/80 gene expression post-
wounding compared to HFD-Sed, with 
expression at day 3 post-wounding the 
most striking difference.  The general curve 
of the data is diagrammed in Figure 5.1.  
This may suggest an exercise effect on the migration of macrophages to the wound site in HFD-fed 
mice.  Alternatively, this finding may simply reflect a differential effect of exercise and sedentary on 
F4/80 gene expression in HFD-fed mice without an actual effect on macrophage number. 
 In order to further examine the potential differences in non-wounded skin macrophage 
number in HFD-Ex and HFD-Sed mice, we sectioned frozen skin tissue and stained for CD68+ cells.  
In support of our gene expression data, macrophage number in the non-wounded skin of HFD-Sed 
mice was slightly elevated, although like the gene expression data, the difference was non-
significant.  Due to the small number of mice used for this analysis, a larger study may be able to 
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Figure 5.1 General kinetic response of F4/80 gene expression 
in HFD-Ex and HFD-Sed mice.  Skin: non-wounded skin 
excised at day 0. Day 1: day 1 post-wounding. Day 3: day 3 
post-wounding. Day 5: day 5 post-wounding.   
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find a significant difference here, especially if skin tissue is harvested and processed specifically for 
immunofluorescence microscopy or flow cytometry.  Antibodies to alternative macrophage cell 
surface markers may also be valuable, as CD68 has been shown to be expressed on epithelial cells 
(31) and other cells which are known to be present in the skin. 
 We also measured gene expression levels of macrophage phenotype markers, including 
TLR4 expression as well as alternatively-activated macrophage markers FIZZ1 and CD206.  We 
found no major effect of either exercise or the wounding process on expression of skin or wound 
TLR4.  Additionally, we found no major effect of exercise or wounding on cell surface marker 
CD206, the mannose receptor.  FIZZ1, a product secreted by alternatively-activated macrophages 
(7), was elevated in HFD-fed mice (irrespective of exercise intervention) in non-wounded skin and 
was significantly reduced thereafter in wounds at day 1, day 3, and day 5 post-wounding.  These 
data suggest that exercise has little effect on macrophage phenotype in these mice.  The reduction 
in expression of FIZZ1 was not surprising as macrophages generally take on a pronounced pro-
inflammatory state early in the wounding process.  It is possible that exercise may differentially 
regulate some of these markers later (after day 5) post-wounding. 
5.1.5 Lean Mice 
 The necessity of a 4 month feeding protocol adds a significant amount of time and expense 
to the study of wound healing in obese mice.  Thus, we were interested if exercise could affect 
healing in young, lean mice in a similar manner.  Previous research in Balb/cByJ mice indicated that 
exercise tended to speed healing, although the exercise effect only approached significance in these 
mice (16).  In the first experiments, we used Chow-fed C57Bl/6J mice of a similar age (6 months) to 
that of the HFD-fed mice.  As previously discussed, exercise failed to speed healing in these mice, 
and neither Chow-Ex nor Chow-Sed healed faster than the HFD-Ex mice.  We followed this up with 
an analysis of healing in young (6-8 week) female and male C57Bl/6J mice to determine both if 
there was an exercise effect in these mice and if there was a differential effect of exercise in male vs. 
85 
 
female mice.  Again, in female mice we were unable to speed healing using our exercise 
intervention, and the overall healing kinetics were quite similar to those seen in the older Chow-Ex, 
Chow-Sed, and HFD-Ex mice in previous experiments.  However, the male mice, although unaffected 
by exercise, healed significantly slower than the female mice in this experiment.  This was the case 
both in wound size at day 1 and day 5 post-wounding as well as in time to total wound closure. 
 In female mice, estrogen plays a major role in protection from obesity-impaired wound 
healing (13).  In the aged mouse study previously performed by our lab (16), the mice were post-
menopausal and thus the majority of the estrogen effect was removed.  However, our mice were 
much younger and pre-menopausal, thus estrogen may be playing a protective role in reducing 
inflammation and speeding healing in these experiments.  This is partially supported by the finding 
that 6 week old male C57Bl/6J mice heal more slowly than their female counterparts.  It is possible 
that an extension of the HFD-feeding study to male mice might demonstrate an exercise effect on 
healing rate and wound inflammation similar to that seen in post-menopausal female mice in our 
previous aging study.   
5.1.6 Adipose Tissue Inflammation 
 One of the more interesting findings to arise from these experiments is the effect of the 
short-term exercise training bout on gene expression of inflammatory markers in adipose tissue.  
We tested gene expression of several cytokines as well as the macrophage marker F4/80 in both 
visceral adipose tissue (epididymal fat pad) and subcutaneous adipose tissue from the vicinity of 
the wound site.  Most previous studies have found reductions in adipose tissue inflammation with 
exercise in obese rodents (1, 15, 17, 23, 32).  However, the vast majority of such studies focus on 
longer-term (weeks to months) exercise training paradigms, whereas our mice exercised for only 5 
days prior to euthanasia and tissue collection. 
 Surprisingly, we found that exercise training caused a general increase in adipose tissue 
expression of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in both adipose tissue depots, 
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although only IL-1β and TNF-α expression in the epididymal adipose tissue rose to the level of 
statistical significance.  These increases were only moderate (2-3 fold), and the significance of this 
finding is not presently clear.  It is possible that this upregulation represents an acute inflammatory 
response to exercise-related factors such as increased circulating free fatty acids or release of 
endogenous factors during cellular damage.  Regardless of the cause, this is an intriguing finding 
and deserves follow-up in future studies. 
 Additionally, exercise training in these obese mice had a differential role in F4/80 gene 
expression in the examined fat depots.  In epididymal adipose tissue, exercise upregulated F4/80 
gene expression 2.5-fold, a finding which nearly achieved significance (p=0.051).  In subcutaneous 
adipose tissue, however, exercise had little effect on F4/80 expression, with an approximately 15% 
reduction which was not nearly statistically significant.  This suggests exercise may have an effect 
on macrophage number in epididymal adipose tissue concomitant with little effect in the 
subcutaneous depot, but the mechanisms by which this differential regulation occurs are not clear 
at this time.  These data, along with the cytokine data discussed above, take into account only gene 
expression and do not consider protein expression in any way.  To confirm these findings, it would 
be imperative to examine the protein expression of the listed cytokines via ELISA, and likely to 
determine the number of F4/80 positive cells in adipose tissue via immunohistochemistry or flow 
cytometry. 
5.1.7 Limitations and Alternate Mechanisms 
 There are some potential limitations to this study,  primary of which is the use of only 
female mice for HFD-feeding studies.  This was done to remain consistent with previous studies in 
aged mice (16) and in restraint-stressed mice (14) as these studies were major sources of 
inspiration for the experiments reported here.  However, both previous studies used mouse strains 
different from the C57Bl/6J strain used in this study (Balb/cByJ and SKH-1 mice, respectively).  The 
choice of C57Bl/6J mice was made due to their suitability as a model of diet-induced obesity (33); 
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this strain of mouse is commonly used in obesity research.  It is possible that exercise induces 
differential effects on wound tissue in these mouse strains, as previous research showed an 
exercise effect on healing rate which approached significance in young, lean Balb/cByJ mice (16), 
while we detected no difference in lean C57Bl/6J mice. 
 Several other potential mechanisms for the exercise effect on wound healing in obese mice 
require further investigation.  Clotting and hemostasis represent the earliest responses to 
wounding (11), happening generally within 30 minutes post-trauma.  Exercise is known to 
positively influence hemostasis, possibly by increasing activity of coagulation factors as well as by 
increasing reactivity of platelets (20).  Obesity and diabetes are linked to a dysregulated hemostasis 
through the maintenance of a pro-coagulant state (6).  Both obesity and sedentary behavior have 
been shown to be risk factors for the development of inflammation and hemostatic imbalances (12).  
Thus, it is possible that exercise-induced alterations in hemostasis may explain the effects of 
exercise in HFD-fed mice seen in this study, and this potential mechanism should be evaluated. 
 A second area which bears consideration for future research is the role of exercise in 
promoting myofibroblast migration and wound contraction in obese mice.  Myofibroblasts are 
specialized cells that induce wound site contraction and are important in the healing of rodent 
tissues (11).  Treadmill running has been previously shown to induce migration of myofibroblasts 
into the patellar tendon of female mice (29), a finding which lends some credence to this 
hypothesis.  Recent evidence indicates that diet-induced obesity causes a delay in myofibroblast 
differentiation in the wound site of HFD-fed rats (25).  Thus, the impact on myofibroblast migration 
and differentiation may be an important mechanism by which exercise exerts its pro-healing effect 
in obese, HFD-fed mice. 
 Finally, a recent area of interest in obesity research is the role of the microbiome on the 
pathogenesis of various aspects of obesity and its associated disorders.  Studies in HFD-fed mice 
indicated that HFD-feeding results in shifts in commensal bacterial populations in the intestine (19) 
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and increases systemic LPS levels (2), and this may play a major role in the increased inflammation 
seen both systemically and locally in HFD-fed obese mice.  However, although the interplay 
between obesity and the intestinal microbiota has been well-studied (and is comprehensively 
reviewed elsewhere (30)), the role of obesity on alterations in the skin microbiome is less clear.  
Complicating such studies is the fact that cutaneous microbial populations vary both intra-
individual (between different skin sites) as well as across the population (10).  Additionally, mice 
are known to have limited skin microbial populations compared to humans, while microbial 
populations on the hairless portion of the mouse ear more closely resemble that of humans (9).  
Thus, the role of obesity-associated alterations of microbial populations, either intestinal or 
cutaneous, in regulating wound healing in mice may be of interest.  Additionally, wound healing in 
hairless portions of mouse skin (such as the ear) may show different responses to exercise in obese 
mice. 
 
5.2 Summary and Future Directions 
 Given the association between obesity and impaired wound healing, we investigated the 
role of short-term exercise training on wound healing rate in obese, high-fat diet-fed mice.  Exercise 
training for 3 days prior to wounding and 5 days post-wounding sped healing, although the effect of 
exercise was limited mostly to early time points post-wounding.  Surprisingly, wound inflammation 
was not altered by exercise, suggesting that exercise in these mice is regulating healing through an 
inflammation-independent mechanism.  Wound macrophage number and wound growth factor 
expression were also unaltered, although there was some indication that exercise might regulate 
wound macrophage number in non-wounded skin.  Exercise training had little effect on glucose 
tolerance in these mice but, interestingly, tended to upregulate gene expression of inflammatory 
markers in several adipose tissue depots.  Finally, our exercise training paradigm was unable to 
speed healing in lean mice, whether male or female, although lean male mice did heal more slowly 
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than their female counterparts.  This suggests a differential effect of sex on healing that might point 
to a potential for a different outcome should this exercise paradigm be used in obese male mice. 
 Future work stemming from these studies should focus on several areas.  First and 
foremost, several findings from the present experiments, including the tendency for exercise to 
decrease skin wound macrophage number and increase adipose tissue inflammation, warrant 
further study on a larger scale.  Additionally, alternative explanations for the exercise effect, 
including increased wound site contraction, improved wound site hemostasis, or altered intestinal 
or skin microbiota, should be investigated.  Also of importance is further study into the time scale 
by which exercise is applied, as it is not currently known whether exercise prior to or after 
wounding is more important, nor is it known for how long after wounding should exercise be 
undertaken for optimal effect.   
 Finally, other types of wound healing events are altered by obesity and may be improved by 
exercise training.  For example, recent evidence indicates that pulmonary wounds induced by 
influenza infection in obese mice fail to heal (22), a potential mechanism for the increased 
morbidity and mortality experienced by obese mice infected with several influenza viruses (3, 22, 
28).  Short-term exercise training has been shown to protect mice from mortality to influenza virus 
in previous studies (21), thus exercise may play a protective role in virally-infected obese mice 
through improvements in pulmonary wound healing.  Thus, there are a number of potential 
avenues to extend the findings of this study into other areas.   
 Perhaps most importantly, human studies are necessary to determine if these types of 
exercise interventions can improve healing in a human population.  Should these studies be 
successful, exercise training could be used clinically as a treatment, with or without pharmaceutical 
interventions, to improve healing in obese individuals.  Thus, it is imperative that work in this area 
continue in order to translate the findings of these experiments into clinically useful techniques to 
promote healing in a population in which impaired wound healing is a severe problem. 
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APPENDIX A 
LIST OF ABBREVIATIONS 
 
+/+; wild-type mouse 
γδ; gamma-delta T lymphocyte 
AAM; alternatively-activated macrophage 
AMPK; 5' adenosine monophosphate-activated protein kinase 
ANOVA; analysis of variance 
AUC; area under the curve 
BMI; body mass index 
BW; body weight 
CAM; classically-activated macrophage 
CD; cluster of differentiation 
CO2; carbon dioxide 
COX; cyclooxygenase 
CRP; C-reactive protein 
CVD; Cardiovascular disease 
DAMP; damage-associated molecular pattern 
DAR; Division of Animal Resources (UIUC) 
db/+; mouse with heterozygous alteration of the leptin receptor gene, non-diabetic 
db/db; mouse with homozygous alteration of the leptin receptor gene, diabetic 
EC; endothelial cell 
ECM; extracellular matrix 
ELISA; enzyme-linked Immunosorbant assay 
FGF; fibroblast growth factor 
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FIZZ; found in inflammatory zone 
FSP; fibroblast specific protein 
GC; glucocorticoid 
GM-CSF; granulocyte/macrophage colony stimulating factor 
H&E; hematoxylin and eosin 
HDL; high-density lipoprotein, “good cholesterol” 
HFD; high-fat diet 
HSP; heat shock protein 
IACUC; Institutional Animal Care and Use Committee (UIUC) 
IFN; interferon 
IGF; insulin-like growth factor 
IHC; immunohistochemistry 
IKK; IκB kinase 
IL; interleukin 
IRS; insulin receptor substrate 
JNK; c-Jun N-terminal kinase 
KC; keratinocyte chemoattractant 
kcal; kilocalories, Calories 
LDL; low-density lipoprotein, “bad cholesterol” 
LPS; lipopolysaccharide 
MΦ; macrophage 
MCP; monocyte chemoattractant protein 
MIP; macrophage inflammatory protein 
MPO; myeloperoxidase 
mRNA; messenger ribonucleic acid 
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NFκB; nuclear factor kappa-B 
NHANES; National Health and Nutrition Examination Survey 
NK; natural killer cell 
NKT; natural killer T lymphocyte 
NSAID; non-steroidal anti-inflammatory drugs 
ob/ob; mouse with homozygous alteration of the leptin gene, diabetic 
OVX; ovariectomized 
PDGF; platelet-derived growth factor 
PMN; polymorphonuclear leukocyte, neutrophil 
PRR; pattern recognition receptor 
PVA; polyvinyl alcohol 
RT-PCR; reverse transcriptase polymerase chain reaction 
SVC; stromal vascular cells, non-adipocytes that are associated with adipose tissue 
T2D; type 2 diabetes mellitus 
TC; CD8+ cytotoxic T lymphocyte 
TGF; transforming growth factor 
TH; CD4+ helper T lymphocyte 
TLR; toll-like receptor 
TNF; tumor necrosis factor 
sTNFR; soluble tumor necrosis factor-alpha receptor 
Strep-HRP; streptavidin-conjugated horseradish peroxidase 
UIUC; University of Illinois at Urbana-Champaign 
VEGF; vascular endothelial growth factor 
VEGFR; vascular endothelial growth factor receptor 
WAT; white adipose tissue 
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RNA ISOLATION BY TRIZOL 
 
Prior to beginning protocol 
□ Turn on laminar flow hood and wait at least 10 minutes before use 
□ Turn on water bath to 55oC 
□ Set microcentrifuge to 4oC 
□ Check that sufficient tubes and homogenizer tips are available 
□ Locate reagents listed below and make as needed 
 
Materials 
□ TRIzol cocktail: 
o TRIzol/QIAzol reagent – 1ml per sample 
o Protease inhibitor (Sigma) - 5μl per sample 
o Phosphatase inhibitor cocktail 2 (Sigma) - 5μl per sample 
o Phosphatase inhibitor cocktail 3 (Sigma) - 5μl per sample 
□ Chloroform or BCP 
□ Isopropyl alcohol (2-propanol) 
□ 75% ethanol in DEPC-treated water 
□ RNase-free water or Tris-EDTA 
□ Frozen tissue samples 
 
RNA isolation 
□ Homogenize frozen tissue samples in TRIzol cocktail for 2-3 minutes 
□ Transfer to 1.5ml microfuge tube 
□ Centrifuge at 12,000×g for 10 minutes at 2-8oC to remove insoluble material 
□ Transfer cleared homogenate to new 1.5ml microfuge tube 
□ Incubate sample for 5 minutes at room temperature 
□ Add 200μl chloroform or 100μl BCP 
□ Shake tube vigorously by hand for 15 sec 
□ Incubate sample for 2-3 minutes at room temperature 
□ Centrifuge at <12,000×g for 15 minutes at 2-8oC 
o Separates into lower red phase, interphase, and colorless aqueous phase 
o RNA is in the top aqueous phase 
o Save lower phases for protein isolation (see page 103) 
□ Transfer aqueous phase to new 1.5ml microfuge tube 
□ Add 500μl of isopropyl alcohol, cap, and vortex 
□ Incubate samples at room temperature for 10 minutes 
□ Centrifuge at <12,000×g for 10 minutes at 2-8oC 
o The RNA precipitate forms a gel-like pellet on the sides and bottom of the tube 
□ Remove the supernatant and discard 
□ Add 1ml of 75% ethanol and mix by vortex 
□ Centrifuge at <7,500×g for 5 minutes at 2-8oC and remove supernatant 
□ Briefly air-dry the RNA pellet for 5-10 minutes (do not let dry completely) 
□ Dissolve RNA in 40μl RNase-free water or Tris-EDTA by passing up-and-down with pipette 
□ Incubate 10 minutes at 55-60oC 
□ Store extracted RNA at -80oC 
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QUANTIFICATION OF RNA BY NANODROP 
 
Materials 
□ Ultrapure ddH2O (provided at site) 
□ Dilution buffer used for samples (DEPC H2O for RNA) 
□ RNA samples to be measured on ice (see page 98) 
□ P-2 or P-10 pipettor and tips 
□ Kimwipes (provided at site) 
 
Preparation 
The ND-1000 can be found in 356 ERML. 
Sample may be used undiluted as long as the concentration is within these limits: 
 Detection lower limit: 2 ng/ul 
 Detection upper limit: 3000 ng/ul (RNA); 3700 ng/ul (dsDNA); 2400 ng/ul (ssDNA) 
 
Initializing and blanking 
□ Open the “ND-1000” program on the desktop. 
□ Select “Nucleic Acid.” 
□ You will see a message box stating, “Ensure sample pedestals are clean and then load a 
water sample…”  Clean by wiping both the upper arms and the lower measurement pedestal 
first with a kimwipe wet with ddH2O and then with a dry kimwipe. 
□ Pipette 2ul ultrapure ddH2O onto the pedestal. 
□ Select “OK.” 
□ After initialization, remove ddH2O and pipette 2 ul of dilution buffer onto the pedestal. 
□ Select the “Blank” button. 
□ After blanking is complete, remove buffer by wiping with a dry kimwipe. 
 
Measurement 
□ Select the type of nucleic acid you will be measuring in the sample type box. 
□ Pipette 2ul of the first sample onto the pedestal.  Close the arm. 
□ Type the sample ID in the sample ID box. 
□ Select the “Measure” button, or press F1. 
□ After measurement is complete, check to be sure that the concentration is within the 
accurate range.  Then remove sample by picking up with pipette and saving, or by wiping 
with a kimwipe (be sure to wipe both the upper arm and the lower pedestal). 
□ Repeat steps 2-6 for each sample. 
□ Clean by wiping first with a wet kimwipe, and then with a dry kimwipe. 
 
Saving data 
□ When all samples are complete, select the “Show Report” button. 
□ Select “Export Report Table Only.” 
□ Find our folder: My Computer  Local Disk C  DataND1000  Woods 
□ Save as a .txt file.  Then open Mozilla Firefox and email the file to yourself. 
□ Exit all windows. 
□ When you return to your lab computer, first save the file from your email to another folder.  
Then right-click the file to open with Excel. 
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REVERSE TRANSCRIPTION TO cDNA 
 
Materials 
□ Applied Biosystems High-Capacity cDNA Reverse Transcription Kits 
□ Nuclease-free H2O 
□ Purified RNA samples with concentrations measured by Nanodrop (see pages 98-99) 
 
Method 
□ Dilute RNA to 0.2 μg/μl using the following steps 
o M1V1 = M2V2 
o (RNA Yield in μg/μl)(V1) = (0.2 μg/μl)(10 μl) 
o V1 = (0.2 μg/μl)(10 μl)/(RNA Yield in μg/μl) 
o V1 = volume of RNA sample to use 
o 10 μl – V1 = volume of DEPC water to use 
o Combine RNA and DEPC H2O for a total volume of 10 μl in an RNA tube 
□ In a larger tube, create RT master mix using the following steps.  Keep on ice.  The examples 
are for 16 rxn.  Total volume per reaction is 10 μl 
o 2.0 μl of 10x RT buffer per reaction  ex: 32 μl 
o 0.8 μl of 25x dNTP mix (100mM)  ex: 12.8 μl 
o 2.0 μl of 10x RT random primers  ex: 32 μl 
o 1.0 μl of MultiScribe reverse transcriptase ex: 16 μl 
o 1.0 μl of RNAse inhibitor   ex: 16 μl 
o 3.2 μl of Nuclease-free H2O   ex: 51.2 μl 
□ Add 10 μl of RT master mix to RNA tube for a total volume of 20 μl 
□ Take samples to thermocycler 
□ Centrifuge samples briefly on small centrifuge 
□ Input temperature protocol into thermocycler  
o Block 1: 10 minutes @ 25oC 
o Block 2: 120 minutes @ 37oC 
o Block 3: 5 minutes@ 85oC 
o Block 4: unlimited @ 6oC 
o Make sure machine is set to 1 cycle only 
o Start reaction 
o When reaction is finished, put cDNA in -20oC freezer 
 
Master mix recipe 
 
Reagent   # samples* × μl/sample = total volume 
RT Buffer                    × 2  =   
dNTP                            × 0.8  =   
Random Primers      × 2  =   
Rev. Transciptase     × 1  =   
RNAse Inhibitor        × 1  =   
Nuclease-free H2O    × 3.2  =   
 
* Always overestimate # of samples necessary so that sufficient master mix is available 
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PREPARATION OF RT-PCR PLATES 
 
 
Materials 
□ 384 well plate 
□ Reverse-transcribed cDNA samples (see pages 98-100) 
□ Nuclease-free H2O 
□ Primers 
□ TaqMan master mix 
 
Method 
□ Locate 384 well plate.  Have plate map template prepared (see page 107). 
□ Each well should have: 5 microliters of TaqMan, .5 microliters of Primer, 1 microliter of 
cDNA, and 3.5 microliters of nuclease free H2O.  The best way to prepare for the plate is:  
o Using a 16 sample example for the gene GAPDH, we will: 
o In a fresh tube:  add 5 microliters TaqMan x 16 samples x 2 (duplicates)  for a total 
of 160 microliters of TaqMan, however we should overestimate our samples to 18 in 
order to not run out, so we will therefore add 180 microliters of TaqMan….In the 
same tube add .5 microliters of Primer x 18 samples (overestimate) x 2 (duplicates) 
for a total of 18 microliters of Primer.  This tube will now have a combined 180 
microliters of TaqMan and 18 microliters of Primers as prepared for an 
overestimated 18 samples.  This will be our GAPDH Master Mix Tube.  We will 
prepare a similar tube for each gene we analyze. 
o In separate fresh tube, we will prepare our sample cDNA.  If we pretend we are 
analyzing three genes, then for each sample we will have 6 wells (3 genes x 2 
duplicates).  It is best to create a sample “master mix.”  In a fresh tube we will add 1 
microliter of cDNA for each well, which is 6 total microliters of cDNA, and 3.5 
microliters of nuclease free H2O per well, which is a total of 21 microliters of 
nuclease free H2O.  Our fresh tube will now contain 3.5 microliters of cDNA and 21 
microliters of nuclease free H2O. 
o In each well, add 5.5 microliters of TaqMan/Primer Master Mix, and 4.5 microliters 
of cDNA/ nuclease free H20 mix for a total well volume of 10 microliters. 
o Cover plate, and either refrigerate plate or take to PCR Machine 
 
Master mix recipe 
 
Reagent  # samples* × μl/sample = total volume 
TaqMan          × 5  =   
Primer      × 0.5  =   
 
* Always overestimate # of samples necessary so that sufficient master mix is available 
   Always run samples in duplicate 
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QUANTIFICATION OF mRNA BY RT-PCR 
 
Materials 
□ Prepared 384 well plate (see page 101) 
□ Blank CD 
 
Method 
□ In the Functional Genomic Suite (ERML 356) room to the right.  Need to sign up for time. 
□ Open the SDS 2.2.1 program on desktop. 
□ There is no password. 
□ File>>New 
□ Click “OK.” 
□ Select the wells that contain your samples. 
□ Click “Add Detector.” 
□ Choose the following detector: “Woods Lab”. 
□ Click “Copy to plate document.” 
□ Click “Done” 
□ Click on “Use” box 
□ Click on “Instruments” tab to check Temps and Sample Volume 
□ Make sure it is on Standard 
□ Change Sample Volume if Necessary to 10µl 
□ Go back to Setup 
□ Centrifuge the plate for 1 minute @ 2000 rpm (program #2); make sure to balance with a 
blank plate if necessary. 
□ Under “Instruments” tab select “Connect” 
□ Under “Instruments” select “open” which should open door of machine. 
□ Load plate into machine, matching A1 in the upper-left hand corner of the DeepWell Stack. 
□ Under “ Instrument” select “close” 
□ Under “Instruments” select  “start” 
□ A pop-up dialogue box will appear and select “Yes” 
□ Save the file to your personal folder under SDS documents. 
□ Once the machine is finished running the plate, retrieve you data. 
□ Open the SDS 2.2.1 Program 
□ File>>Open ( choose your file) 
□ Select the wells that contain your samples 
□ Under the “Analysis” tab select “Analyze” (If “Negative Signal Warning” pops up, click OK).  
May need to go to “Analysis”>>Analysis Settings>>switch to Auto Ct. 
□ Under the “Results” tab, a graph should appear depicting Ct thresholds for all your samples. 
□ Ct values should be in a table to the left, highlighted in yellow. 
□ File>>Save (save in same folder as before) 
□ File>> Export (Export to blank CD) 
□ Close program when finished. 
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PROTEIN ISOLATION BY TRIZOL 
 
Prior to beginning protocol 
□ Turn on laminar flow hood and wait at least 10 minutes before use 
□ Turn on water bath to 55oC 
□ Set microcentrifuge to 4oC 
□ Check that sufficient tubes and homogenizer tips are available 
□ Locate reagents listed below and make as needed 
 
Materials 
□ 100% ethanol 
□ Isopropyl alcohol 
□ 0.3M guanidine hydrochloride in 95% ethanol 
o 1.43g of Guanidine HCl (ICN Biomedicals) in 50ml 95% ethanol 
o Store at room temperature 
o Mix thoroughly prior to use 
□ 1% SDS in RNase-free water 
 
Method 
□ Beginning with lower phases after removal of BCP-isolated RNA upper phase (see page 98) 
□ Remove remaining aqueous phase and precipitate DNA with 300μl 100% ethanol 
□ Mix by inversion 
□ Incubate sample at room temperature for 2-3 minutes 
□ Centrifuge at 2,000×g for 5 minutes at 2-8oC 
□ Remove phenol-ethanol supernatant (contains the protein) and transfer to new tube 
□ Add 1.5ml isopropyl alcohol, cap, and vortex 
□ Incubate samples for 10 minutes at room temperature 
□ Centrifuge at 12,000×g for 10 minutes at 2-8oC 
□ Remove supernatant and wash the protein pellet 3 times via following method 
o Add 2ml of 0.3M guanidine hydrochloride in 95% ethanol 
o Incubate protein pellet in wash solution for 20 minutes at room temperature 
o Centrifuge at 7,500×g for 5 minutes at 2-8oC 
o Repeat 
o Pellet can be stored in 0.3M guanidine HCl solution at 4oC for up to 1 month 
□ Vortex final protein pellet in 2ml of ethanol 
□ Incubate 20 minutes at room temperature  
□ Centrifuge at 7,500×g for 5 minutes at 2-8oC 
□ Dry protein pellet for 5-10 minutes 
□ Dissolve in 1% SDS by pipetting (500-1000μl per sample) 
□ Incubate sample at 50oC 
□ Sediment insoluble material by centrifugation at 10,000×g for 10 minutes at 2-8oC 
□ Transfer supernatant to new tube and store at (-5) to (-20)oC for use in Western Blot 
 
Note: protein isolated by this method is not suitable for use in ELISA or multiplex assays 
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PROTEIN ISOLATION FOR ELISA 
 
Materials 
□ Ice-cold PBS 
□ Protease inhibitor (Sigma) - 5μl per sample 
□ Phosphatase inhibitor cocktail 2 (Sigma) - 5μl per sample 
□ Phosphatase inhibitor cocktail 3 (Sigma) - 5μl per sample 
□ Frozen tissue samples 
 
Method 
□ Homogenize frozen tissue samples in PBS supplemented with protease and phosphatase 
inhibitors for 2-3 minutes. 
□ Transfer samples to 1.5ml microfuge tube and centrifuge at 10,000×g for 20 minutes. 
□ Remove supernatant (contains protein), transfer to clean tube, and store at -20oC until 
analysis. 
□ Quantify protein concentration using protein assay (see page 105) 
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QUANTIFICATION OF PROTEIN CONCENTRATION 
 
Materials 
□ Isolated protein samples (see pages 104 and 105) 
□ 96-well plate 
□ DC Protein Assay kit (BioRad) 
 
Method 
□ Add 20 µL of reagent S to each mL of reagent A that will be needed for the reaction.   
□ Prepare BSA standards in serial dilution starting at 10mg/ml 
□ Pipet 5 µL of standards into a clean, dry microplate. 
□ Pipet 2 µL of samples into a clean, dry microplate. 
□ Add 25 µL of working reagent A into each well. 
□ Add 200 µL of reagent B into each well.  Pop any bubbles with a clean pipet tip. 
□ After 15 minutes, absorbances can be read at 750nm with plate shaking to mix reagents 
o Absorbances will be stable for 1 hour 
□ Multiply values by dilution factor of 2.5 when analyzing data 
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PLATE MAP TEMPLATES 
 
96 well plates 
 
 
Plate   Study    Tech   Date   
  1 2 3 4 5 6 7 8 9 10 11 12 
A                         
B                         
C                         
D                         
E                         
F                         
G                         
H                         
 
Plate   Study    Tech   Date   
  1 2 3 4 5 6 7 8 9 10 11 12 
A                         
B                         
C                         
D                         
E                         
F                         
G                         
H                         
 
Plate   Study    Tech   Date   
  1 2 3 4 5 6 7 8 9 10 11 12 
A                         
B                         
C                         
D                         
E                         
F                         
G                         
H                         
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384 well plate 
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HEMATOXYLIN AND EOSIN STAINING 
 
Materials 
□ Prepared slides with frozen wound sections  
□ 10% neutral buffered formalin 
□ PBS 
□ Hematoxylin solution 
□ Eosin solution 
□ 75%, 85%, 95%, 100% ethanol 
□ Xylenes 
□ Coverslip 
 
Method 
□ Take slide from freezer and immediately submerge in formalin for 10 min (do not let dry) 
□ Wash well in several changes of PBS, then rinse in water 
□ Incubate in hematoxylin solution for 2-5 min followed by rinses in dH2O 
□ Blue in ammonia water (0.25% ammonia hydroxide in dH2O) or other bluing solution 
(including lukewarm tap water), followed by rinses in dH2O 
□ Dehydrate to 95% ethanol (75% EtOH, 85% EtOH, 95% EtOH 3 min ea.) 
□ Dip for 10-20 sec in alcoholic eosin 
□ Proceed through at least 2 more changes of 95% ethanol, 100% ethanol, xylenes 
□ Add coverslip and observe under brightfield 
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IMMUNOFLUORESCENCE STAINING 
 
Materials 
□ Prepared slides with frozen wound sections  
□ PBS 
□ Coplin jars 
□ Pre-cooled acetone (-20oC) 
□ Pap pen 
□ 10% serum in PBS* 
□ Humidified chamber 
□ Primary and secondary antibodies 
□ Antibody dilution buffer 
□ 50% glycerol in PBS supplemented with DAPI 
 
Method 
□ Air-dry slide for 10 min at RT 
□ Rehydrate slide for 10 min at RT in coplin jar 
□ Fix slide in pre-cooled acetone for 10 min at RT in coplin jar 
□ Air-dry slide for 10 min (make sure slide is completely dry) 
□ Circle sections with pap pen 
□ Wash in PBS, 3 min × 2 washes 
□ Block with 10% serum* in PBS (~50µl/sample) for 30 min at RT in humidified chamber 
□ Wash as previously 
□ Add primary antibody (~50µl/sample) at appropriate concentration and incubate 45 min in 
humidified chamber chamber (or overnight at 4oC) 
□ Wash as previously 
□ Add secondary antibody (~50ul/sample) and incubate 45 min in humidified chamber (in 
the dark) 
□ Wash as previously (in the dark) 
□ Wet-mount sections with 50% glycerol in PBS with DAPI or dry-mount using a permanent 
mounting medium with DAPI 
□ Observe under fluorescent microscope 
□ Store in slide book at 4oC for 3-6 months 
 
Antibody dilution buffer 
□ 100ml PBS 
□ 1g BSA 
□ 50mg Sodium Azide 
 
* Use normal serum from species from which the secondary antibody is derived 
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IMMUNOHISTOCHEMISTRY 
 
Materials 
□ Prepared slides with frozen wound sections  
□ PBS 
□ Coplin jars 
□ H2O2  solution (varies) 
□ Pre-cooled acetone (-20oC) 
□ Pap pen 
□ 10% serum in PBS* 
□ BSA solution 
□ Humidified chamber 
□ Primary and secondary antibodies 
□ Vectastain Elite ABC reagent 
□ AEC peroxidase solution 
□ Hematoxylin 
□ Aqueous mounting medium (e.g. VectaMount AQ) 
□ Coverslip 
 
Method 
□ Air dry slides for 10 min at RT 
□ Fix slides in pre-cooled acetone for 10 min at RT in coplin jar 
□ Remove acetone and circle tissue sections with pap pen 
□ Transfer slides to PBS at RT in coplin jar 
□ Remove excess PBS and wipe with Kimwipe around wells 
□ Quench endogenous peroxidase activity with 0.3% H2O2/0.3% serum*/PBS for 5 min  
□ Wash in PBS 
□ Block with 15µl of 10% serum* diluted in 1ml of BSA solution in humidified chamber 
□ Remove excess serum from wells 
□ Add primary antibody (~50µl/sample) and incubate 30 min at RT in humidified chamber 
□ Wash slides in PBS 
□ Add secondary antibody (~50µl/sample) and incubate 30 min at RT in humidified chamber 
□ Wash slides in PBS 
□ Add Vectastain Elite ABC Reagent and incubate 30 min at RT in humidified chamber 
□ Wash slides in PBS 
□ Add AEC peroxidase substrate solution and incubate at RT until desired stain intensity 
□ Rinse sections in tap water 
□ Counterstain with hematoxylin (incubation times vary) 
□ Rinse sections in tap water 
□ Mount in aqueous mounting medium and place coverslip on top 
□ Observe under brightfield 
 
BSA Solution  
□ 100ml PBS 
□ 0.1g BSA 
□ 0.01% Azide 
 
* Use normal serum from species from which the secondary antibody is derived 
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GLUCOSE TOLERANCE TESTING 
 
Materials 
□ Insulin syringes with attached needles 
□ 10% glucose solution 
o Ex: 1 g glucose in 10 ml sterile water 
□ Scissors 
□ OneTouch Ultra Mini glucometer and test strips 
 
Method 
□ Fast mice overnight (~12 hr) 
□ Weigh mice and record body weight 
□ Snip tail and, following glucometer instructions, record blood glucose (time 0) 
□ Give 10% glucose solution i.p. at dosage of 1 g glucose per kg body weight immediately 
following measurement 
□ Repeat tail snip and glucose measurement at 30, 60, 90, and 120 minutes post-injection 
□ Return food to mice after final blood glucose measurement 
□ Express data as area under the glucose response curve 
 
